Director / AV Gallery

A-
A
A+

Publications & Research

FOR ALL INDEXED PUBLICATION: PLEASE LOG ON TO
https://www.ncbi.nlm.nih.gov/pubmed/?term=dhiman+rk

Citations [h-index = 64]
FOR CITATIONS OF ARTICLES PUBLISHED IN INDEXED JOURNALS[GOOGLE SCHOLER]

https://scholar.google.co.in/citations?user=uo7xk04AAAAJ&hl=en

Total publications	All	Since 2019l
Citations	15630	7536
h-index	64	43
i10-index	242	156
Amongst 2% world top scientists according to Stanford List

Citations

SlNo	Title	Citations
1.	Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. S Prasad, RK Dhiman, A Duseja, YK Chawla, A Sharma, R Agarwal. Hepatology 2007;45 (3), 549-559	717
2.	Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. SK Sarin, A Choudhury, MK Sharma, R Maiwall, M Al Mahtab, S Rahman, RK Dhiman...Hepatology international 2019;13 (4), 353-390	686
3.	Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. A Das, RK Dhiman, VA Saraswat, M Verma, SR Naik. Journal of gastroenterology and hepatology 2001;16 (5), 531-535	381
4.	Herbal medicines for liver diseases. RK Dhiman, YK Chawla. Digestive diseases and sciences 2005;50 (10), 1807-1812	378
5.	Probiotic VSL# 3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. RK Dhiman, B Rana, S Agrawal, A Garg, M Chopra, KK Thumburu, ...Gastroenterology 2014;147 (6), 1327-1337	367
6.	Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. CF Rose, P Amodio, JS Bajaj, RK Dhiman, S Montagnese, ...Journal of hepatology 73 (6), 1526-1547	301
7.	Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literatureRK Dhiman, Y Chawla, RK Vasishta, N Kakkar, JB Dilawari, MS Trehan, ...Journal of gastroenterology and hepatology 2002;17 (1), 6-16	275
8.	Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. A Gupta, RK Dhiman, S Kumari, S Rana, R Agarwal, A Duseja, Y Chawla. Journal of hepatology 53 (5), 849-855	248
9.	Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. RK Dhiman, R Kurmi, KK Thumburu, SH Venkataramarao, R Agarwal, ...Digestive diseases and sciences 2010;55 (8), 2381-2390	235
10.	The modern management of portal vein thrombosis. Y Chawla, A Duseja, RK Dhiman. Alimentary pharmacology & therapeutics 2009;30 (9), 881-894	227
11.	Portal hypertensive biliopathy. RK Dhiman, A Behera, YK Chawla, JB Dilawari, S Suri. Gut 2007;56 (7), 1001-1008	219
12.	Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. SK Sarin, A Kumar, YK Chawla, SS Baijal, RK Dhiman, W Jafri, ...Hepatology international 2007;1 (3), 398-413	204
13.	Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. RK Dhiman, VA Saraswat, BK Sharma, SK Sarin, YK Chawla, ...Journal of Gastroenterology and Hepatology 2010;25 (6), 1029-1041	189
14.	Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease. S Kapil, A Duseja, BK Sharma, B Singla, A Chakraborti, A Das, P Ray, ...Journal of gastroenterology and hepatology 2016;31 (1), 213-221	188
15.	Non-alcoholic fatty liver disease and metabolic syndrome—position paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian …A Duseja, SP Singh, VA Saraswat, SK Acharya, YK Chawla, S Chowdhury, ...Journal of clinical and experimental hepatology 2015;5 (1), 51-68	184
16.	Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria. RK Dhiman, S Jain, U Maheshwari, A Bhalla, N Sharma, J Ahluwalia, ...Liver transplantation 2007;13 (6), 814-821	182
17.	Gut microbiota: its role in hepatic encephalopathy. R Rai, VA Saraswat, RK Dhiman. Journal of clinical and experimental hepatology 2015;5, S29-S36	181
18.	Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. RK Dhiman, IMS Sawhney, YK Chawla, G Das, S Ram, JB DilawariDigestive diseases and sciences 2000;45 (8), 1549-1552	175
19.	Biliary changes in extrahepatic portal venous obstruction: compression by collaterals or ischemic?RK Dhiman, P Puri, Y Chawla, M Minz, JR Bapuraj, S Gupta, B Nagi, ...Gastrointestinal endoscopy 1999;50 (5), 646-652	170
20.	Endoscopic sclerotherapy of gastric variceal bleeding with N-butyl-2-cyanoacrylate. RK Dhiman, Y Chawla, S Taneja, R Biswas, TR Sharma, JB Dilawari. Journal of clinical gastroenterology 2002;35 (3), 222-227.	162
21.	Evaluation of abnormal liver function tests. S Agrawal, RK Dhiman, JK Limdi. Postgraduate medical journal 2016;92 (1086), 223-234	159
22.	Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepatic portal venous obstruction. D Gupta, DR Vijaya, R Gupta, RK Dhiman, M Bhargava, J Verma, ...The American journal of gastroenterology 2001;96 (12), 3395-3399	153
23.	The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. A Duseja, A Das, R Das, RK Dhiman, Y Chawla, A Bhansali, N Kalra. Digestive diseases and sciences 2007;52 (9), 2368-2374	148
24.	Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. RK Dhiman, AK Seth, S Jain, YK Chawla, JB DilawariDigestive diseases and sciences 1998;43 (6), 1311-1316	146
25.	Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. A Duseja, A Das, RK Dhiman, YK Chawla, KK Thumburu, S Bhadada, ...Annals of hepatology 2007;6 (4), 222-226	144
26.	Minimal hepatic encephalopathy. RK Dhiman, YK Chawl. Indian Journal of Gastroenterology 2009;28 (1), 5-16	137
27.	APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF). A Duseja, NS Choudhary, S Gupta, RK Dhiman, Y Chawla. Journal of digestive diseases 2013;14 (9), 484-490	122
28.	Rupture of hepatocellular carcinoma: a review of literature. SK Sahu, YK Chawla, RK Dhiman, V Singh, A Duseja, S Taneja, N Kalra, ...Journal of clinical and experimental hepatology 9 (2), 245-256	116
29.	Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver …RK Dhiman, S Agrawal, T Gupta, A Duseja, Y Chawla. World journal of gastroenterology: WJG 2014;20 (40), 14934	111
30.	Figure connection test: a universal test for assessment of mental state. RK DHIMAN, VA SARASWAT, M VERMA, SR NAIK. Journal of gastroenterology and hepatology 1995;10 (1), 14-23	110
31.	Wilson's disease: clinical practice guidelines of the Indian national association for study of the liver, the Indian society of pediatric gastroenterology, hepatology and …A Nagral, MS Sarma, J Matthai, PL Kukkle, H Devarbhavi, S Sinha, ...Journal of clinical and experimental hepatology 9 (1), 74-98	109
32.	Non-cirrhotic portal hypertension in pregnancy. N Aggarwal, H Sawhney, K Vasishta, RK Dhiman, Y Chawla. International journal of gynecology& obstetrics 2001; 72 (1), 1-7	107
33.	Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect of bile acid therapy. BC Sharma, DK Agarwal, RK Dhiman, SS Baijal, G Choudhuri, ...Gastroenterology 1998;115 (1), 124-128	105
34.	Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver. RK Dhiman, VA Saraswat, DC Valla, Y Chawla, A Behera, V Varma, ...Journal of clinical and experimental hepatology 2014;4, S2-S14	104
35.	Patients with nonalcoholic fatty liver disease (NAFLD) have higher oxidative stress in comparison to chronic viral hepatitis. A Kumar, A Sharma, A Duseja, A Das, RK Dhiman, YK Chawla, KK Kohli, ...Journal of clinical and experimental hepatology 2013;3 (1), 12-18	99
36.	Minimal hepatic encephalopathy impairs quality of life. S Agrawal, S Umapathy, RK Dhiman. Journal of clinical and experimental hepatology 5, S42-S48	99
37.	Role of paraoesophageal collaterals and perforating veins on outcome of endoscopic sclerotherapy for oesophageal varices: an endosonographic study.RK Dhiman, G Choudhuri, VA Saraswat, DK Agarwal, SR Naik. Gut 1996;38 (5), 759-764	97
38.	Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure (ACLF). A Duseja, YK Chawla, RK Dhiman, A Kumar, N Choudhary, S Taneja. Digestive diseases and sciences 2010;55 (11), 3188-3192	97
39.	Consensus statement of HCV task force of the Indian National Association for Study of the Liver (INASL). Part I: Status report of HCV infection in India. P Puri, AC Anand, VA Saraswat, SK Acharya, RK Dhiman, R Aggarwal, ...Journal of clinical and experimental hepatology 2014;4 (2), 106-116	93
40.	Pregnancy with portal hypertension. N Aggarwal, N Negi, A Aggarwal, V Bodh, RK Dhiman. Journal of clinical and experimental hepatology 2014;4 (2), 163-171	90
41.	Prevention and management of bacterial infections in cirrhosis. SK Taneja, RK Dhiman. International journal of hepatology 2011	86
42.	Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI). S Saigal, S Gupta, S Sudhindran, N Goyal, A Rastogi, M Jacob, K Raja, ...Hepatology international 14 (4), 429-431.	85
43.	Radioisotope scintigraphy in the diagnosis of hepatic hydrothorax. A Bhattacharya, BR Mittal, T Biswas, RK Dhiman, B Singh, SK Jindal, ..Journal of gastroenterology and hepatology 2001;16 (3), 317-321	84
44.	APASL ACLF Research Consortium (AARC) for APASL ACLF working Party SK Sarin, A Choudhury, MK Sharma, R Maiwall, M Al Mahtab, S Rahman, ... Acute-on-chronic liver failure: consensus recommendations of the Asian …. Hepatology International	84
45.	Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis. A Sharma, A Chakraborti, A Das, RK Dhiman, Y Chawla. Immunology 2009;128 (1pt2), e514-e522	83
46.	Duplex Doppler sonography in patients with Budd–Chiari syndrome. Y Chawla, S Kumar, RK Dhiman, S Suri, JB Dilawari. Journal of gastroenterology and hepatology 1999;14 (9), 904-907	82
47.	Pregnancy and cirrhosis of the liver. N Aggarwal, H Sawnhey, V Suril, K Vasishta, M Jha, RK Dhiman. Australian and New Zealand journal of obstetrics and gynaecology1999;39 (4), 503-506	82
48.	Comparative efficacy of treatment options for minimal hepatic encephalopathy: a systematic review and network meta-analysis RK Dhiman, KK Thumburu, N Verma, M Chopra, S Rathi, U Dutta, ... Clinical gastroenterology and hepatology 18 (4), 800-812. e25	82
49.	Endosonographic, endoscopic, and histologic evaluation of alterations in the rectal venous system in patients with portal hypertension. RK Dhiman, VA Saraswat, G Choudhuri, BC Sharma, R Pandey, SR Naik. Gastrointestinal endoscopy 1999;49 (2), 218-227	81
50.	Percutaneous catheter drainage of amoebic liver abscess. VA Saraswat, DK Agarwal, SS Baijal, S Roy, G Choudhuri, RK Dhiman, ...Clinical radiology 1992;45 (3), 187-189	80
51.	Endosonographic evaluation of the venous anatomy around the gastro-esophageal junction in patients with portal hypertension.GChoudhuri, RK Dhiman, DK Agarwal. Hepato-gastroenterology 1996;43 (11), 1250-1255	80
52.	Gut microbiota and hepatic encephalopathy. RK Dhiman. Metabolic brain disease 28 (2), 321-326	79
53.	Hepatic encephalopathy. D Häussinger, RK Dhiman, V Felipo, B Görg, R Jalan, G Kircheis, M Merli, ...Nature Reviews Disease Primers 8 (1), 43	76
54.	CYP2C19 genetic mutations in North Indians. JK Lamba, RK Dhiman, KK Kohli. Clinical Pharmacology & Therapeutics 2000;68 (3), 328-335	75
55.	Flare of autoimmune hepatitis causing acute on chronic liver failure: diagnosis and response to corticosteroid therapy. L Anand, A Choudhury, C Bihari, BC Sharma, M Kumar, R Maiwall, ...Hepatology 70 (2), 587-596	73
56.	Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections. N Verma, S Singh, S Taneja, A Duseja, V Singh, RK Dhiman, ...Liver International 39 (3), 503-513	73
57.	Nonalcoholic fatty liver in a developing country is responsible for significant liver disease. A Duseja, B Sharma, A Kumar, S Kapil, A Das, RK Dhiman, YK Chawla. Hepatology 52 (6), 2248-2249	70
58.	Drug-induced acute-on-chronic liver failure in Asian patients. H Devarbhavi, AK Choudhury, MK Sharma, R Maiwall, M Al Mahtab, et al American College of Gastroenterology\| ACG 114	67
59.	Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosis. J Samanta, RK Dhiman, A Khatri, KK Thumburu, S Grover, A Duseja, ...Metabolic brain disease 28 (2), 249-259	67
60.	Correlation of 24-hr esophageal pH patterns with clinical features and endoscopy in gastroesophageal reflux disease. VA Saraswat, RK Dhiman, A Mishra, SR Naik. Digestive diseases and sciences 1994;39 (1), 199205	66
61.	A guide to the management of tuberculosis in patients with chronic liver disease. RK Dhiman, VA Saraswat, H Rajekar, C Reddy, YK Chawla. Journal of Clinical and Experimental Hepatology 2 (3), 260-270	65
62.	Hepatitis B and C virus--prevalence and prevention in health care workers. A Duseja, L Arora, B Masih, H Singh, A Gupta, D Behera, YK Chawla, ...Tropical gastroenterology: official journal of the Digestive Diseases 2002…	65
63.	Hepatitis B virus co-infection in HIV infected patients.A Sud, J Singh, RK Dhiman, A Wanchu, S Singh, Y Chawla. Tropical gastroenterology: official journal of the Digestive Diseases 2001…	64
64.	Hepatic arteriovenous fistulae: role of interventional radiology. A Kumar, CK Ahuja, S Vyas, N Kalra, N Khandelwal, Y Chawla, ...Digestive diseases and sciences 57 (10), 2703-2712	64

HEPATIC ENCEPHALOPATHY

SlNo	Title
	I. HEPATIC ENCEPHALOPATHY
1.	Häussinger D, Dhiman RK, Felipo V, Görg B, Jalan R, Kircheis G, Merli M, Montagnese S, Romero-Gomez M, Schnitzler A, Taylor-Robinson SD, Vilstrup H. Hepatic encephalopathy.Nat Rev Dis Primers. 2022 Jun 23;8(1):43. doi: 10.1038/s41572-022-00366-6.PMID: 35739133 Review.
2.	Mehtani R, Premkumar M, Garg S, Kajal K, Kulkarni AV, Duseja AK, Dhiman RK, De A, Verma N, Taneja S, Rathi S, Singh V, Chakma J, Soni SL, Kakkar A, Kapila AT, Ahuja CK, Divyaveer S, Praharaj D.Intravenous BCAA Infusion Does Not Lead to a Sustained Recovery From Overt HE in ACLF - An Open Label Randomized Clinical Trial.J Clin Exp Hepatol. 2023 Nov-Dec;13(6):977-988. doi: 10.1016/j.jceh.2023.05.015. Epub 2023 Jun 1.PMID: 37975059
3.	Verma N, Dhiman RK, Choudhury A, Taneja S, Duseja A, Singh V, Al Mahtab M, Devarbhavi H, Shukla A, Ning Q, Hamid SS, Butt AS, Jafri W, Tan SS, Hu J, Zhongping D, Treeprasertsuk S, Lee GH, Ghazinyan H, Lesmana LA, Sood A, Midha V, Goyal O, Kim DJ, Eapen CE, Goel A, Tao H, Shaojie X, Yuemin N, Dokmeci AK, Sahu M, Singh A, Arora A, Kumar A, Kumar R, Prasad VGM, Shresta A, Sollano J, Payawal DA, Shah S, Rao PN, Kulkarni A, Lau GK, Sarin SK; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Dynamic assessments of hepatic encephalopathy and ammonia levels predict mortality in acute-on-chronic liver failure. Hepatol Int. 2021 Aug;15(4):970-982. doi: 10.1007/s12072-021-10221-7. Epub 2021 Jul 18.PMID: 34275111
4.	Gupta P, Vyas S, Salan T, Jain C, Taneja S, Dhiman RK, Singh P, Ahuja CK, Ray N, Govind V. Whole brain atlas-based diffusion kurtosis imaging parameters for evaluation of minimal hepatic encephalopathy.Neuroradiol J. 2022 Feb;35(1):67-76. doi: 10.1177/19714009211026924. Epub 2021 Jun 29.PMID: 34187242 Free PMC article.
5.	Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD, Vilstrup H, Jalan R. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. J Hepatol. 2020 Dec;73(6):1526-1547. doi: 10.1016/j.jhep.2020.07.013. Epub 2020 Oct 21.PMID: 33097308 Review.
6.	Ahmed S, Premkumar M, Dhiman RK, Kulkarni AV, Imran R, Duseja A, Kaur P, Taneja S, Singh V, Mishra S, Roy A, Mehtani R. Combined PEG3350 Plus Lactulose Results in Early Resolution of Hepatic Encephalopathy and Improved 28-Day Survival in Acute-on-Chronic Liver Failure. J Clin Gastroenterol. 2022 Jan 1;56(1):e11-e19. doi: 10.1097/MCG.0000000000001450.PMID: 33060437 Clinical Trial.
7.	Agarwal A, Taneja S, Chopra M, Duseja A, Dhiman RK. Animal Naming Test - a simple and accurate test for diagnosis of minimal hepatic encephalopathy and prediction of overt hepatic encephalopathy.Clin Exp Hepatol. 2020 Jun;6(2):116-124. doi: 10.5114/ceh.2019.95105. Epub 2020 May 8.PMID: 32728628 Free PMC article
8.	Bajaj JS, Lauridsen M, Tapper EB, Duarte-Rojo A, Rahimi RS, Tandon P, Shawcross DL, Thabut D, Dhiman RK, Romero-Gomez M, Sharma BC, Montagnese S. Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus. Am J Gastroenterol. 2020 Jul;115(7):989-1002. doi: 10.14309/ajg.0000000000000603.PMID: 32618647
9.	Rathi S, Chopra M, Chouduri G, Sharma P, Madan K, Chhabra M, Rai RR, Govil A, Konar A, Goenka M, Agarwal M, Mukherjee J, Thorat V, Salunkhe S, Abraham P, Nagral A, Jhaveri A, Bhat N, Varghese J, R S A, Ravishankar, Reddy DC, Dhiman RK. Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Cross-Sectional, Clinicoepidemiological, Multicenter, Nationwide Study in India: The PREDICT Study. J Clin Exp Hepatol. 2019 Jul-Aug;9(4):476-483. doi: 10.1016/j.jceh.2018.09.009. Epub 2018 Oct 15.PMID: 31516264 Free PMC article.
10.	Dhiman RK, Thumburu KK, Verma N, Chopra M, Rathi S, Dutta U, Singal AK, Taneja S, Duseja A, Singh M. Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis. Clin Gastroenterol Hepatol. 2020 Apr;18(4):800-812.e25. doi: 10.1016/j.cgh.2019.08.047. Epub 2019 Aug 30.PMID: 31476436
11.	Premkumar M, Dhiman RK. Special Section: Update in Hepatic Encephalopathy- Part III. J Clin Exp Hepatol. 2019 Jan-Feb;9(1):2-3. doi: 10.1016/j.jceh.2019.01.002. Epub 2019 Jan 25.PMID: 30765932 Free PMC article. No abstract available.
12.	Premkumar M, Dhiman RK. UPDATE IN HEPATIC ENCEPHALOPATHY - PART II. J Clin Exp Hepatol. 2018 Dec;8(4):333-334. doi: 10.1016/j.jceh.2018.11.001. Epub 2018 Nov 29.PMID: 30568343 Free PMC article. No abstract available.
13.	Vankadari K, Mittal BR, Kumar R, Singh H, Bhattacharya A, Dhiman RK. Detection of Hepatic Encephalopathy on 18F-FDG PET/CT Brain Images in a Patient With Decompensated Liver Cirrhosis. Clin Nucl Med. 2018 Dec;43(12):e486-e487. doi: 10.1097/RLU.0000000000002327.PMID: 30325817
14.	Premkumar M, Dhiman RK. Update in Hepatic Encephalopathy. J Clin Exp Hepatol. 2018 Sep;8(3):217-218. doi: 10.1016/j.jceh.2018.09.001. Epub 2018 Oct 4.PMID: 30302035 Free PMC article. No abstract available.
15.	Rathi S, Fagan A, Wade JB, Chopra M, White MB, Ganapathy D, Acharya C, Dhiman RK, Bajaj JS. Patient Acceptance of Lactulose Varies Between Indian and American Cohorts: Implications for Comparing and Designing Global Hepatic Encephalopathy Trials. J Clin Exp Hepatol. 2018 Jun;8(2):109-115. doi: 10.1016/j.jceh.2017.11.010. Epub 2017 Dec 2.PMID: 29892171 Free PMC article.
16.	Rathi S, Dhiman RK.Managing encephalopathy in the outpatient setting. Clin Liver Dis (Hoboken). 2016 Dec 30;8(6):150-155. doi: 10.1002/cld.590. eCollection 2016 Dec.PMID: 31041084 Free PMC article. Review. No abstract available.
17.	Taneja S, Dhiman RK. Can Testing the Impact of Minimal Hepatic Encephalopathy on Driving Skills be Prolific to Translate Research to Real Life Clinical Medicine? J Clin Exp Hepatol. 2016 Mar;6(1):1-2. doi: 10.1016/j.jceh.2016.03.007. Epub 2016 May 4.PMID: 27194888 Free PMC article. No abstract available.
18.	Rai R, Ahuja CK, Agrawal S, Kalra N, Duseja A, Khandelwal N, Chawla Y, Dhiman RK. Reversal of Low-Grade Cerebral Edema After Lactulose/Rifaximin Therapy in Patients with Cirrhosis and Minimal Hepatic Encephalopathy. Clin Transl Gastroenterol. 2015 Sep 17;6(9):e111. doi: 10.1038/ctg.2015.38.PMID: 26378384 Free PMC article.
19.	Agrawal S, Umapathy S, Dhiman RK. Minimal hepatic encephalopathy impairs quality of life. J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S42-8. doi: 10.1016/j.jceh.2014.11.006. Epub 2014 Dec 4.PMID: 26041957 Free PMC article. Review.
20.	Rai R, Saraswat VA, Dhiman RK. Gut microbiota: its role in hepatic encephalopathy. J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S29-36. doi: 10.1016/j.jceh.2014.12.003. Epub 2014 Dec 16.PMID: 26041954 Free PMC article. Review.
21.	Dhiman RK. Hepatic encephalopathy. J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S1-2. doi: 10.1016/j.jceh.2015.02.001.PMID: 26041949 Free PMC article. No abstract available.
22.	Dhiman RK. Impact of minimal/covert hepatic encephalopathy on patients with cirrhosis. Clin Liver Dis (Hoboken). 2015 Apr 21;5(3):75-78. doi: 10.1002/cld.452. eCollection 2015 Mar.PMID: 31040955 Free PMC article. Review. No abstract available.
23.	Dhiman RK, Rana B, Agrawal S, Garg A, Chopra M, Thumburu KK, Khattri A, Malhotra S, Duseja A, Chawla YK. Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. Gastroenterology. 2014 Dec;147(6):1327-37.e3. doi: 10.1053/j.gastro.2014.08.031. Epub 2014 Aug 27.PMID: 25450083 Clinical Trial.
24.	Umapathy S, Dhiman RK, Grover S, Duseja A, Chawla YK. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Am J Gastroenterol. 2014 Jul;109(7):1011-9. doi: 10.1038/ajg.2014.107. Epub 2014 Apr 29.PMID: 24777152
25.	Thumburu KK, Dhiman RK, Vasishta RK, Chakraborti A, Butterworth RF, Beauchesne E, Desjardins P, Goyal S, Sharma N, Duseja A, Chawla Y. Expression of astrocytic genes coding for proteins implicated in neural excitation and brain edema is altered after acute liver failure. J Neurochem. 2014 Mar;128(5):617-27. doi: 10.1111/jnc.12511. Epub 2013 Nov 14.PMID: 24164438 Free article.
26.	Rai R, Dhiman RK. Dopamine in the pathogenesis of minimal hepatic encephalopathy: a new player? Hepatol Int. 2013 Jul;7(3):795-7. doi: 10.1007/s12072-013-9465-9. Epub 2013 Sep 10.PMID: 26201915 No abstract available.
27.	Samanta J, Dhiman RK, Khatri A, Thumburu KK, Grover S, Duseja A, Chawla Y. Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosis. Metab Brain Dis. 2013 Jun;28(2):249-59. doi: 10.1007/s11011-013-9393-3. Epub 2013 Mar 15.PMID: 23494591
28.	Dhiman RK. Gut microbiota and hepatic encephalopathy. Metab Brain Dis. 2013 Jun;28(2):321-6. doi: 10.1007/s11011-013-9388-0. Epub 2013 Mar 6.PMID: 23463489 Review.
29.	Taneja S, Dhiman RK, Khatri A, Goyal S, Thumbru KK, Agarwal R, Duseja A, Chawla Y. Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver. J Clin Exp Hepatol. 2012 Dec;2(4):306-14. doi: 10.1016/j.jceh.2012.07.001. Epub 2012 Dec 16.PMID: 25755452 Free PMC article.
30.	Dhiman RK. Gut microbiota, inflammation and hepatic encephalopathy: a puzzle with a solution in sight. J Clin Exp Hepatol. 2012 Sep;2(3):207-10. doi: 10.1016/j.jceh.2012.08.004.PMID: 25755435 Free PMC article. No abstract available.
31.	Sunil HV, Mittal BR, Kurmi R, Chawla YK, Dhiman RK. Brain perfusion single photon emission computed tomography abnormalities in patients with minimal hepatic encephalopathy. J Clin Exp Hepatol. 2012 Jun;2(2):116-21. doi: 10.1016/S0973-6883(12)60099-1. Epub 2012 Jul 21.PMID: 25755420 Free PMC article.
32.	Gupta A, Dhiman RK, Kumari S, Rana S, Agarwal R, Duseja A, Chawla Y. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol. 2010 Nov;53(5):849-55. doi: 10.1016/j.jhep.2010.05.017. Epub 2010 Jul 17.PMID: 20675008
33.	Dhiman RK, Saraswat VA, Sharma BK, Sarin SK, Chawla YK, Butterworth R, Duseja A, Aggarwal R, Amarapurkar D, Sharma P, Madan K, Shah S, Seth AK, Gupta RK, Koshy A, Rai RR, Dilawari JB, Mishra SP, Acharya SK; Indian National Association for Study of the Liver. Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol. 2010 Jun;25(6):1029-41. doi: 10.1111/j.1440-1746.2010.06318.x.PMID: 20594216 Review.
34.	Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, Chawla Y. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci. 2010 Aug;55(8):2381-90. doi: 10.1007/s10620-010-1249-7. Epub 2010 May 28.PMID: 20508990
35.	Dhiman RK, Chawla YK. Minimal hepatic encephalopathy. Indian J Gastroenterol. 2009 Jan-Feb;28(1):5-16. doi: 10.1007/s12664-009-0003-6.PMID: 19529896 Review.
36.	Dhiman RK, Chawla YK. Minimal hepatic encephalopathy: time to recognise and treat. Trop Gastroenterol. 2008 Jan-Mar;29(1):6-12.PMID: 18564660 Review.
37.	Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007 Mar;45(3):549-59. doi: 10.1002/hep.21533.PMID: 17326150 Clinical Trial.
38.	Dhiman RK, Chawla YK. Minimal hepatic encephalopathy: should we start treating it? Gastroenterology. 2004 Dec;127(6):1855-7. doi: 10.1053/j.gastro.2004.10.034.PMID: 15578528 No abstract available.
39.	Gupta RK, Dhiman RK. Magnetic resonance imaging and spectroscopy in hepatic encephalopathy. Indian J Gastroenterol. 2003 Dec;22 Suppl 2:S45-9.PMID: 15025255 Review.
40.	Duseja A, Dhiman RK, Saraswat VA, Chawla Y. Minimal hepatic encephalopathy: natural history, impact on daily functioning, and role of treatment. Indian J Gastroenterol. 2003 Dec;22 Suppl 2:S42-4.PMID: 15025254 Review.
41.	Kharbanda PS, Saraswat VA, Dhiman RK. Minimal hepatic encephalopathy: diagnosis by neuropsychological and neurophysiologic methods. Indian J Gastroenterol. 2003 Dec;22 Suppl 2:S37-41.PMID: 15025253 Review.
42.	Duseja A, Sachdev A, Dhiman RK, Chawla YK. Helicobacter pylori and hepatic encephalopathy. Indian J Gastroenterol. 2003 Dec;22 Suppl 2:S31-2.PMID: 15025251 Review.
43.	Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol. 2001 May;16(5):531-5. doi: 10.1046/j.1440-1746.2001.02487.x.PMID: 11350549
44.	Dhiman RK, Sawhney MS, Chawla YK, Das G, Ram S, Dilawari JB. Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Dig Dis Sci. 2000 Aug;45(8):1549-52. doi: 10.1023/a:1005556826152.PMID: 11007104 Clinical Trial.
45.	Dhiman RK, Seth AK, Jain S, Chawla YK, Dilawari JB. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci. 1998 Jun;43(6):1311-6. doi: 10.1023/a:1018876328561.PMID: 9635624
46.	Dhiman RK, Saraswat VA, Verma M, Naik SR. Figure connection test: a universal test for assessment of mental state. J Gastroenterol Hepatol. 1995 Jan-Feb;10(1):14-23. doi: 10.1111/j.1440-1746.1995.tb01041.x.PMID: 7620102
47.	Gupta RK, Saraswat VA, Poptani H, Dhiman RK, Kohli A, Gujral RB, Naik SR. Magnetic resonance imaging and localized in vivo proton spectroscopy in patients with fulminant hepatic failure. Am J Gastroenterol. 1993 May;88(5):670-4.PMID: 8480729

LIVER CIRRHOSIS AND PORTAL HYPERTENSION

SlNo	Title
	I. LIVER CIRRHOSIS AND PORTAL HYPERTENSION
1.	Bajaj JS, Choudhury AK, Xie Q, Kamath PS, Topazian M, Hayes PC, Torre A, Desalegn H, Idilman R, Cao Z, Alvares-da-Silva MR, George J, Bush BJ, Thacker LR, Wong F; CLEARED Investigators. Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium. Lancet Gastroenterol Hepatol. 2023 Jul;8(7):611-622. doi: 10.1016/S2468-1253(23)00098-5. Epub 2023 May 22.PMID: 37230109 Free PMC article.
2.	Singh S, Taneja S, Roy A, Rathi S, De A, Verma N, Premkumar M, Duseja A, Dhiman RK, Singh V. Simple bedside tests of muscle strength and function correlate with computed tomography-skeletal muscle index for assessment of sarcopenia in cirrhosis. Indian J Gastroenterol. 2023 May 24. doi: 10.1007/s12664-023-01338-8. Online ahead of print.PMID: 37222972
3.	Taneja S, Mehtani R, De A, Mitra S, Rathi S, Verma N, Premkumar M, Minz R, Duseja A, Das A, Singh V, Dhiman RK, Chawla YK. Spectrum of Autoimmune Liver Disease and Real-World Treatment Experience from a Tertiary Care Hospital. J Clin Exp Hepatol. 2023 Mar-Apr;13(2):241-251. doi: 10.1016/j.jceh.2022.11.002. Epub 2022 Nov 10.PMID: 36950480
4.	Meena BL, Taneja S, Tandon P, Sahni N, Soundararajan R, Gorsi U, De A, Verma N, Premkumar M, Duseja A, Dhiman RK, Singh V. Home-based intensive nutrition therapy improves frailty and sarcopenia in patients with decompensated cirrhosis: A randomized clinical trial. J Gastroenterol Hepatol. 2023 Feb;38(2):210-218. doi: 10.1111/jgh.16035. Epub 2022 Nov 9.PMID: 36268614 Clinical Trial.
5.	Singh S, Taneja S, Tandon P, De A, Verma N, Premkumar M, Duseja A, Dhiman RK, Singh V.High Prevalence of Hormonal Changes and Hepatic Osteodystrophy in Frail Patients with Cirrhosis-An Observational Study.J Clin Exp Hepatol. 2022 May-Jun;12(3):800-807. doi: 10.1016/j.jceh.2021.11.012. Epub 2021 Nov 26.PMID: 35677501 Free PMC article.
6.	Singh S, Taneja S, Tandon P, Bansal A, Gorsi U, Roy A, De A, Verma N, Premkumar M, Duseja A, Dhiman RK, Singh V. A Comparison of Different Frailty Scores and Impact of Frailty on Outcome in Patients With Cirrhosis. J Clin Exp Hepatol. 2022 Mar-Apr;12(2):398-408. doi: 10.1016/j.jceh.2021.07.003. Epub 2021 Jul 21.PMID: 35535083 Free PMC article.
7.	Praharaj DL, Premkumar M, Roy A, Verma N, Taneja S, Duseja A, Dhiman RK. Rifaximin Vs. Norfloxacin for Spontaneous Bacterial Peritonitis Prophylaxis: A Randomized Controlled Trial. J Clin Exp Hepatol. 2022 Mar-Apr;12(2):336-342. doi: 10.1016/j.jceh.2021.08.010. Epub 2021 Aug 18.PMID: 35535057 Free PMC article.
8.	Chugh Y, Katoch S, Sharma D, Bahuguna P, Duseja A, Kaur M, Dhiman RK, Prinja S. Health-Related Quality of Life Among Liver Disorder Patients in Northern India. Indian J Community Med. 2022 Jan-Mar;47(1):76-81. doi: 10.4103/ijcm.ijcm_1033_21. Epub 2022 Mar 16.PMID: 35368487 Free PMC article.
9.	Premkumar M, Dhiman RK. Portal Cavernoma Cholangiopathy: Indian Perspective. Clin Liver Dis (Hoboken). 2021 Oct 15;18(3):127-137. doi: 10.1002/cld.1130. eCollection 2021 Sep.PMID: 34691399 Free PMC article. Review. No abstract available.
10.	Arora A, Kumar A, Prasad N, Duseja A, Acharya SK, Agarwal SK, Aggarwal R, Anand AC, Bhalla AK, Choudhary NS, Chawla YK, Dhiman RK, Dixit VK, Gopalakrishnan N, Gupta A, Hegde UN, Jasuja S, Jha V, Kher V, Kumar A, Madan K, Maiwall R, Mathur RP, Nayak SL, Pandey G, Pandey R, Puri P, Rai RR, Raju SB, Rana DS, Rao PN, Rathi M, Saraswat VA, Saxena S, Shalimar, Sharma P, Singh SP, Singal AK, Soin AS, Taneja S, Varughese S. INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease.J Clin Exp Hepatol. 2021 May-Jun;11(3):354-386. doi: 10.1016/j.jceh.2020.09.005. Epub 2020 Oct 9.PMID: 33994718 Free PMC article. Review.
11.	Ragate DC, Taneja S, Roy A, Duseja AK, Dhiman RK, Singh V. Idiopathic Hypercalcemia in Decompensated Cirrhosis: Reexploring an Entity in Oblivion. J Clin Exp Hepatol. 2021 Mar-Apr;11(2):270-272. doi: 10.1016/j.jceh.2020.05.004. Epub 2020 May 11.PMID: 33746454 Free PMC article.
12.	Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC, Arora A, Acharya SK, Benjamin J, Chawla YK, Dadhich S, Duseja A, Eapan CE, Goel A, Kalra N, Kapoor D, Kumar A, Madan K, Nagral A, Pandey G, Rao PN, Saigal S, Saraf N, Saraswat VA, Saraya A, Sarin SK, Sharma P, Shalimar, Shukla A, Sidhu SS, Singh N, Singh SP, Srivastava A, Wadhawan M. Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver. J Clin Exp Hepatol. 2021 Jan-Feb;11(1):97-143. doi: 10.1016/j.jceh.2020.09.003. Epub 2020 Oct 1.PMID: 33679050 Free PMC article. Review.
13.	Shrestha D, Rathi S, Grover S, Taneja S, Duseja A, Chawla YK, Dhiman RK. Factors Affecting Psychological Burden on the Informal Caregiver of Patients with Cirrhosis: Looking Beyond the Patient. J Clin Exp Hepatol. 2020 Jan-Feb;10(1):9-16. doi: 10.1016/j.jceh.2019.06.002. Epub 2019 Jun 19.PMID: 32025162 Free PMC article.
14.	Thakur J, Rathi S, Grover S, Chopra M, Agrawal S, Taneja S, Duseja A, Bhansali A, Chawla YK, Dhiman RK. Tadalafil, a Phosphodiesterase-5 Inhibitor, Improves Erectile Dysfunction in Patients With Liver Cirrhosis. J Clin Exp Hepatol. 2019 May-Jun;9(3):312-317. doi: 10.1016/j.jceh.2018.07.007. Epub 2018 Aug 18.PMID: 31360023 Free PMC article.
15.	Gupta T, Lochan D, Verma N, Rathi S, Agrawal S, Duseja A, Taneja S, Chawla YK, Dhiman RK. Prediction of 28-day mortality in acute decompensation of cirrhosis through the presence of multidrug-resistant infections at admission.J Gastroenterol Hepatol. 2020 Mar;35(3):461-466. doi: 10.1111/jgh.14788. Epub 2019 Aug 29.PMID: 31334860
16.	Gupta P, Kalra N, Gulati A, Chandel K, Priyaranjan P, Dahal P, Sinha SK, Duseja A, Dhiman RK, Sandhu MS. Changes in liver morphology in patients with extrahepatic portal venous obstruction: a retrospective magnetic resonance imaging study. Br J Radiol. 2019 Jun;92(1098):20180890. doi: 10.1259/bjr.20180890. Epub 2019 Apr 9.PMID: 30924678 Free PMC article.
17.	Anand L, Choudhury A, Bihari C, Sharma BC, Kumar M, Maiwall R, Siam Tan S, Shah SR, Hamid S, Butt AS, Jafri W, Chawla YK, Taneja S, Duseja A, Dhiman RK, Mahtab MA, Ghazinyan H, Duan Z, Chen Y, Shukla A, Hu J, Abbas Z, Treeprasertsuk S, Lesmana LA, Lesmana CR, Sollano JD, Carpio G, Sahu MK, Kumar G, Sarin SK; APASL ACLF (APASL ACLF Research Consortium) Working Party. Flare of Autoimmune Hepatitis Causing Acute on Chronic Liver Failure: Diagnosis and Response to Corticosteroid Therapy. Hepatology. 2019 Aug;70(2):587-596. doi: 10.1002/hep.30205. Epub 2019 Feb 22.PMID: 30113706
18.	Taneja S, Borkakoty A, Rathi S, Kumar V, Duseja A, Dhiman RK, Gupta KL, Chawla Y. Assessment of Liver Fibrosis by Transient Elastography Should Be Done After Hemodialysis in End Stage Renal Disease Patients with Liver Disease. Dig Dis Sci. 2017 Nov;62(11):3186-3192. doi: 10.1007/s10620-017-4777-6. Epub 2017 Sep 25.PMID: 28948504
19.	Taneja S, Kumar P, Gautam V, Duseja A, Singh V, Dhiman RK, Chawla Y. Spontaneous Bacterial Peritonitis by Burkholderiacepacia Complex: A Rare, Difficult to Treat Infection in Decompensated Cirrhotic Patients. J Clin Exp Hepatol. 2017 Jun;7(2):102-106. doi: 10.1016/j.jceh.2016.08.008. Epub 2016 Aug 28.PMID: 28663673 Free PMC article.
20.	Ramanathan S, Khandelwal N, Kalra N, Bhatia A, Dhiman RK, Duseja AK, Chawla YK. Correlation of HVPG level with ctp score, MELD Score, ascites, size of varices, and etiology in cirrhotic patients. Saudi J Gastroenterol. 2016 Mar-Apr;22(2):109-15. doi: 10.4103/1319-3767.164185.PMID: 26997216 Free PMC article.
21.	Saraswat VA, Rai P, Kumar T, Mohindra S, Dhiman RK. Endoscopic management of portal cavernoma cholangiopathy: practice, principles and strategy. J Clin Exp Hepatol. 2014 Feb;4(Suppl 1):S67-76. doi: 10.1016/j.jceh.2013.08.011. Epub 2013 Oct 22.PMID: 25755598 Free PMC article. Review.
22.	Dhiman RK, Saraswat VA, Valla DC, Chawla Y, Behera A, Varma V, Agarwal S, Duseja A, Puri P, Kalra N, Rameshbabu CS, Bhatia V, Sharma M, Kumar M, Gupta S, Taneja S, Kaman L, Zargar SA, Nundy S, Singh SP, Acharya SK, Dilawari JB. Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver. J Clin Exp Hepatol. 2014 Feb;4(Suppl 1):S2-S14. doi: 10.1016/j.jceh.2014.02.003. Epub 2014 Feb 25.PMID: 25755591 Free PMC article. Review.
23.	Rathor M, Lal A, Dhiman RK.Patient with liver cirrhosis and hemorrhagic ascites. J Clin Exp Hepatol. 2014 Jun;4(2):178. doi: 10.1016/j.jceh.2014.06.002. Epub 2014 Jun 20.PMID: 25755555 Free PMC article. No abstract available.
24.	Aggarwal N, Negi N, Aggarwal A, Bodh V, Dhiman RK. Pregnancy with portal hypertension. J Clin Exp Hepatol. 2014 Jun;4(2):163-71. doi: 10.1016/j.jceh.2014.05.014. Epub 2014 Jun 23.PMID: 25755552 Free PMC article. Review.
25.	Dhiman RK. Liver-bud Transplantation: A Bud That May Bloom into the Future of Regenerative Medicine. J Clin Exp Hepatol. 2013 Sep;3(3):179-80. doi: 10.1016/j.jceh.2013.09.002.PMID: 25755497 Free PMC article. No abstract available.
26.	Aggarwal N, Suri V, Chopra S, Sikka P, Dhiman RK, Chawla YK. Pregnancy outcome in Budd Chiari Syndrome--a tertiary care centre experience. Arch Gynecol Obstet. 2013 Oct;288(4):949-52. doi: 10.1007/s00404-013-2834-8. Epub 2013 Apr 17.PMID: 23591763
27.	Gupta S, Chawla Y, Kaur J, Saxena R, Duseja A, Dhiman RK, Choudhary NS. Indocyanine green clearance test (using spectrophotometry) and its correlation with model for end stage liver disease (MELD) score in Indian patients with cirrhosis of liver. Trop Gastroenterol. 2012 Apr-Jun;33(2):129-34. doi: 10.7869/tg.2012.30.PMID: 23025060
28.	Dhiman RK, Saraswat VA, Rajekar H, Reddy C, Chawla YK. A guide to the management of tuberculosis in patients with chronic liver disease. J Clin Exp Hepatol. 2012 Sep;2(3):260-70. doi: 10.1016/j.jceh.2012.07.007. Epub 2012 Sep 21.PMID: 25755442 Free PMC article. Review.
29.	Taneja SK, Dhiman RK. Prevention and management of bacterial infections in cirrhosis. Int J Hepatol. 2011;2011:784540. doi: 10.4061/2011/784540. Epub 2011 Aug 28.PMID: 22229097 Free PMC article.
30.	Anand MS, Bahl A, Bodh V, Dhiman RK. Recent onset dyspnea in a patient with cirrhosis of liver. J Clin Exp Hepatol. 2011 Dec;1(3):212. doi: 10.1016/S0973-6883(11)60241-7. Epub 2012 Jan 2.PMID: 25755390 Free PMC article. No abstract available.
31.	Chawla YK, Kashinath RC, Duseja A, Dhiman RK. Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores. J Clin Exp Hepatol. 2011 Dec;1(3):161-8. doi: 10.1016/S0973-6883(11)60233-8. Epub 2012 Jan 2.PMID: 25755381 Free PMC article.
32.	Taneja S, Chawla Y, Dhiman RK. Noncirrhotic portal fibrosis: a rare cause of end-stage liver disease requiring liver transplantation. Hepatol Int. 2013 Jun;7(2):313-5. doi: 10.1007/s12072-011-9311-x. Epub 2011 Sep 3.PMID: 22020827 No abstract available.
33.	Rajekar H, Vasishta RK, Chawla YK, Dhiman RK. Noncirrhotic portal hypertension. J Clin Exp Hepatol. 2011 Sep;1(2):94-108. doi: 10.1016/S0973-6883(11)60128-X. Epub 2011 Nov 9.PMID: 25755321 Free PMC article. Review.
34.	Dhiman RK. Spectrum of idiopathic noncirrhotic portal hypertension. J Clin Exp Hepatol. 2011 Sep;1(2):55-6. doi: 10.1016/S0973-6883(11)60122-9.PMID: 25755315 Free PMC article. No abstract available.
35.	Taneja S, Dhiman RK. Non-cirrhotic Portal Fibrosis and Gamma-Gandy Bodies. J Clin Exp Hepatol. 2011 Jun;1(1):48. doi: 10.1016/S0973-6883(11)60119-9. Epub 2011 Aug 26.PMID: 25755312 Free PMC article. No abstract available.
36.	Choudhary NS, Tomar M, Chawla YK, Bhadada SK, Khandelwal N, Dhiman RK, Duseja A, Bhansali A. Hepatic osteodystrophy is common in patients with noncholestatic liver disease. Dig Dis Sci. 2011 Nov;56(11):3323-7. doi: 10.1007/s10620-011-1722-y. Epub 2011 May 15.PMID: 21573732
37.	Dhiman RK, Chowdhry N, Chawla YK. Has the time come for cyanoacrylate injection to become the standard-of-care for gastric varices? Trop Gastroenterol. 2010 Jul-Sep;31(3):141-4.PMID: 21560516 No abstract available.
38.	Aggarwal N, Chopra S, Raveendran A, Suri V, Dhiman RK, Chawla YK. Extra hepatic portal vein obstruction and pregnancy outcome: largest reported experience. J ObstetGynaecol Res. 2011 Jun;37(6):575-80. doi: 10.1111/j.1447-0756.2010.01407.x.Epub 2011 Mar 6.PMID: 21375674
39.	Sharma M, Babu CS, Dhiman RK, Chawla Y. Induced hypotension in the management of acute hemobilia during therapeutic ERCP in a patient with portal biliopathy (with videos). GastrointestEndosc. 2010 Dec;72(6):1317-9. doi: 10.1016/j.gie.2010.04.020. Epub 2010 Jun 19.PMID: 20561622 No abstract available.
40.	Sodhi KS, Saxena AK, Khandelwal N, Dhiman RK. Giant paraumblical veins in Cruveilhier-Baumgarten syndrome. GastrointestEndosc. 2010 Aug;72(2):435-6; discussion 436. doi: 10.1016/j.gie.2010.02.005. Epub 2010 Jun 11.PMID: 20538272 No abstract available.
41.	Taneja S, Kalra N, Duseja A, Dhiman RK. Noncirrhotic portal fibrosis and abdominal varices. Liver Int. 2010 May;30(5):715-7. doi: 10.1111/j.1478-3231.2010.02224.x.Epub 2010 Mar 18.PMID: 20331506 No abstract available.
42.	Taneja S, Kalra N, Dhiman RK, Chawla YK. An abnormal portal vein. Liver Int. 2011 Jan;31(1):65. doi: 10.1111/j.1478-3231.2009.02175.x.PMID: 19968783 No abstract available.
43.	Chawla Y, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis. Aliment PharmacolTher. 2009 Nov 1;30(9):881-94. doi: 10.1111/j.1365-2036.2009.04116.x.Epub 2009 Aug 12.PMID: 19678814 Free article. Review.
44.	Sarin SK, Kumar A, Angus PW, Baijal SS, Chawla YK, Dhiman RK, Janaka de Silva H, Hamid S, Hirota S, Hou MC, Jafri W, Khan M, Lesmana LA, Lui HF, Malhotra V, Maruyama H, Mazumder DG, Omata M, Poddar U, Puri AS, Sharma P, Qureshi H, Raza RM, Sahni P, Sakhuja P, Salih M, Santra A, Sharma BC, Shah HA, Shiha G, Sollano J; APASL Working Party on Portal Hypertension. Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver. Hepatol Int. 2008 Dec;2(4):429-39. doi: 10.1007/s12072-008-9096-8. Epub 2008 Sep 5.PMID: 19669318 Free PMC article.
45.	Chawla Y, Dhiman RK. Intrahepatic portal venopathy and related disorders of the liver. Semin Liver Dis. 2008 Aug;28(3):270-81. doi: 10.1055/s-0028-1085095. Epub 2008 Sep 23.PMID: 18814080 Review.
46.	Das K, Singh P, Chawla Y, Duseja A, Dhiman RK, Suri S. Magnetic resonance imaging of brain in patients with cirrhotic and non-cirrhotic portal hypertension. Dig Dis Sci. 2008 Oct;53(10):2793-8. doi: 10.1007/s10620-008-0383-y. Epub 2008 Aug 8.PMID: 18688722
47.	Sarin SK, Kumar A, Chawla YK, Baijal SS, Dhiman RK, Jafri W, Lesmana LA, Guha Mazumder D, Omata M, Qureshi H, Raza RM, Sahni P, Sakhuja P, Salih M, Santra A, Sharma BC, Sharma P, Shiha G, Sollano J; Members of the APASL Working Party on Portal Hypertension. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int. 2007 Sep;1(3):398-413. doi: 10.1007/s12072-007-9010-9. Epub 2007 Sep 11.PMID: 19669336 Free PMC article.
48.	Dhillon BK, Das R, Garewal G, Chawla Y, Dhiman RK, Das A, Duseja A, Chandak GR. Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. World J Gastroenterol. 2007 Jun 7;13(21):2956-9. doi: 10.3748/wjg.v13.i21.2956.PMID: 17589946 Free PMC article.
49.	Dhiman RK, Behera A, Chawla YK, Dilawari JB, Suri S. Portal hypertensive biliopathy. Gut. 2007 Jul;56(7):1001-8. doi: 10.1136/gut.2006.103606. Epub 2006 Dec 14.PMID: 17170017 Free PMC article. Review. No abstract available.
50.	Vaiphei K, Saikia UN, Thapa BR, Walker R, Sodhi KS, Dhiman RK. Macronodular cirrhosis and fever in a boy. Indian J Gastroenterol. 2006 Sep-Oct;25(5):251-5.PMID: 17090844 No abstract available.
51.	Dhiman RK, Chawla YK. Herbal medicines for liver diseases. Dig Dis Sci. 2005 Oct;50(10):1807-12. doi: 10.1007/s10620-005-2942-9.PMID: 16187178 Review.
52.	Chawla Y, Dhiman RK. Portal biliopathy: emerging management problems. Trop Gastroenterol. 2003 Oct-Dec;24(4):165-6.PMID: 15164525 No abstract available.
53.	Kumar R, Chawla YK, Garg SK, Dixit RK, Satapathy SK, Dhiman RK, Bhargava VK. Pharmacokinetics of omeprazole in patients with liver cirrhosis and extrahepatic portal venous obstruction. Methods Find Exp Clin Pharmacol. 2003 Oct;25(8):625-30. doi: 10.1358/mf.2003.25.8.778083.PMID: 14671680
54.	Dhiman RK, Chawla YK. A new technique of combined endoscopic sclerotherapy and ligation for variceal bleeding. World J Gastroenterol. 2003 May;9(5):1090-3. doi: 10.3748/wjg.v9.i5.1090.PMID: 12717863 Free PMC article.
55.	Satapathy SK, Dixit RK, Chawla YK, Kumar R, Garg SK, Dhiman RK, Bhargava VK. Pharmacokinetics of ciprofloxacin in extrahepatic portal venous obstruction. Indian J Gastroenterol. 2002 Jul-Aug;21(4):166-7.PMID: 12385555 No abstract available.
56.	Dhiman RK, Chawla Y, Taneja S, Biswas R, Sharma TR, Dilawari JB. Endoscopic sclerotherapy of gastric variceal bleeding with N-butyl-2-cyanoacrylate. J Clin Gastroenterol. 2002 Sep;35(3):222-7. doi: 10.1097/00004836-200209000-00005.PMID: 12192197
57.	Dixit RK, Satapathy SK, Kumar R, Dhiman RK, Garg SK, Taneja S, Bhargava VK, Chawla YK. Pharmacokinetics of ciprofloxacin in patients with liver cirrhosis. Indian J Gastroenterol. 2002 Mar-Apr;21(2):62-3.PMID: 11990328
58.	Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, Puri P, Mitra SK, Suri S. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol. 2002 Jan;17(1):6-16. doi: 10.1046/j.1440-1746.2002.02596.x.PMID: 11895549 Review.
59.	Gupta D, Vijaya DR, Gupta R, Dhiman RK, Bhargava M, Verma J, Chawla YK. Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepatic portal venous obstruction. Am J Gastroenterol. 2001 Dec;96(12):3395-9. doi: 10.1111/j.1572-0241.2001.05274.x.PMID: 11774955
60.	Makharia G, Dhiman RK, Chawla YK, Vasistha RK. Non-cirrhotic portal fibrosis in a patient with rheumatoid arthritis. Indian J Gastroenterol. 2001 Sep-Oct;20(5):197-8.PMID: 11676333
61.	Satapathy SK, Narayan S, Varma N, Dhiman RK, Varma S, Chawla Y. Hyposplenism in alcoholic cirrhosis, facts or artifacts? A comparative analysis with non-alcoholic cirrhosis and extrahepatic portal venous obstruction. J Gastroenterol Hepatol. 2001 Sep;16(9):1038-43. doi: 10.1046/j.1440-1746.2001.02567.x.PMID: 11595070
62.	Bhattacharya A, Mittal BR, Biswas T, Dhiman RK, Singh B, Jindal SK, Chawla Y. Radioisotope scintigraphy in the diagnosis of hepatic hydrothorax. J Gastroenterol Hepatol. 2001 Mar;16(3):317-21. doi: 10.1046/j.1440-1746.2001.02441.x.PMID: 11339424
63.	Aggarwal N, Sawhney H, Vasishta K, Dhiman RK, Chawla Y. Non-cirrhotic portal hypertension in pregnancy. Int J Gynaecol Obstet. 2001 Jan;72(1):1-7. doi: 10.1016/s0020-7292(00)00263-0.PMID: 11146070
64.	Gupta D, Chawla YK, Dhiman RK, Suri S, Dilawari JB. Clinical significance of patent paraumbilical vein in patients with liver cirrhosis. Dig Dis Sci. 2000 Sep;45(9):1861-4. doi: 10.1023/a:1005505522151.PMID: 11052332
65.	Gupta D, Lalrothuama, Agrawal PN, Aggarwal AN, Dhiman RK, Behera D, Chawla Y. Pulmonary function changes after large volume paracentesis. Trop Gastroenterol. 2000 Apr-Jun;21(2):68-70.PMID: 10881627
66.	Dhiman RK, Chawla YK. Is the technique of endoscopic sclerotherapy and ligation (ESL) optimum? GastrointestEndosc. 2000 May;51(5):639-40. doi: 10.1016/s0016-5107(00)70319-1.PMID: 10805868 No abstract available.
67.	Aggarwal N, Sawnhey H, Suril V, Vasishta K, Jha M, Dhiman RK. Pregnancy and cirrhosis of the liver. Aust N Z J ObstetGynaecol. 1999 Nov;39(4):503-6. doi: 10.1111/j.1479-828x.1999.tb03145.x.PMID: 10687776
68.	Dhiman RK, Biswas R, Aggarwal N, Sawhney H, Chawla Y. Management of variceal bleeding in pregnancy with endoscopic variceal ligation and N-butyl-2-cyanoacrylate: report of three cases. GastrointestEndosc. 2000 Jan;51(1):91-3. doi: 10.1016/s0016-5107(00)70398-1.PMID: 10625810 No abstract available.
69.	Dhiman RK, Puri P, Chawla Y, Minz M, Bapuraj JR, Gupta S, Nagi B, Suri S. Biliary changes in extrahepatic portal venous obstruction: compression by collaterals or ischemic? GastrointestEndosc. 1999 Nov;50(5):646-52. doi: 10.1016/s0016-5107(99)80013-3.PMID: 10536320
70.	Chawla Y, Kumar S, Dhiman RK, Suri S, Dilawari JB. Duplex Doppler sonography in patients with Budd-Chiari syndrome. J Gastroenterol Hepatol. 1999 Sep;14(9):904-7. doi: 10.1046/j.1440-1746.1999.01969.x.PMID: 10535473
71.	Garewal G, Das R, Chawla Y, Dhiman RK. Budd-Chiari syndrome associated with homozygous factor V Leiden mutation. Br J Haematol. 1999 Jun;105(3):842. doi: 10.1046/j.1365-2141.1999.01487.x.PMID: 10354159 Free article. No abstract available.
72.	Dhiman RK, Saraswat VA, Choudhuri G, Sharma BC, Pandey R, Naik SR. Endosonographic, endoscopic, and histologic evaluation of alterations in the rectal venous system in patients with portal hypertension. GastrointestEndosc. 1999 Feb;49(2):218-27. doi: 10.1016/s0016-5107(99)70490-6.PMID: 9925702 Clinical Trial.
73.	Sagarad SV, Chawla YK, Dhiman RK. Portal hemodynamics after large-volume paracentesis in patients with liver cirrhosis and tense ascites. Dig Dis Sci. 1998 Nov;43(11):2470-2. doi: 10.1023/a:1026638316826.PMID: 9824136
74.	Das R, Garewal G, Chawla Y, Dhiman RK. Prevalence of the factor V Leiden mutation in portal and hepatic vein thrombosis. Gut. 1998 Jul;43(1):147. doi: 10.1136/gut.43.1.146b.PMID: 9771422 Free PMC article. No abstract available.
75.	Chawla Y, Santa N, Dhiman RK, Dilawari JB. Portal hemodynamics by duplex Doppler sonography in different grades of cirrhosis. Dig Dis Sci. 1998 Feb;43(2):354-7. doi: 10.1023/a:1018814624307.PMID: 9512130
76.	Dhiman RK, Chawla YK. Images in hepatology. Large splenorenal shunt in portal venous obstruction. J Hepatol. 1997 Jul;27(1):216.PMID: 9252099 No abstract available.
77.	Chawla YK, Dilawari JB, Dhiman RK, Goenka MK, Bhasin DK, Kochhar R, Singh K, Kaur U. Sclerotherapy in noncirrhotic portal fibrosis. Dig Dis Sci. 1997 Jul;42(7):1449-53. doi: 10.1023/a:1018858525312.PMID: 9246045
78.	Yachha SK, Dhiman RK, Gupta R, Ghoshal UC. Endosonographic evaluation of the rectum in children with extrahepatic portal venous obstruction. J Pediatr Gastroenterol Nutr. 1996 Nov;23(4):438-41. doi: 10.1097/00005176-199611000-00014.PMID: 8956183
79.	Choudhuri G, Dhiman RK, Agarwal DK. Endosonographic evaluation of the venous anatomy around the gastro-esophageal junction in patients with portal hypertension. Hepatogastroenterology. 1996 Sep-Oct;43(11):1250-5.PMID: 8908559
80.	Dhiman RK, Choudhuri G, Saraswat VA, Agarwal DK, Naik SR. Role of paraoesophageal collaterals and perforating veins on outcome of endoscopic sclerotherapy for oesophageal varices: an endosonographic study. Gut. 1996 May;38(5):759-64. doi: 10.1136/gut.38.5.759.PMID: 8707125 Free PMC article. Clinical Trial.
81.	Sharma BC, Saraswat VA, Dhiman RK, Ghoshal UC, Puri AS, Sikora SS. Unusual tumors causing extrahepatic portal venous obstruction. HPB Surg. 1996;9(3):165-7. doi: 10.1155/1996/72709.PMID: 8725458 Free PMC article.
82.	Dhiman RK, Choudhuri G, Saraswat VA, Mukhopadhyay DK, Khan EM, Pandey R, Naik SR. Endoscopic ultrasonographic evaluation of the rectum in cirrhotic portal hypertension. GastrointestEndosc. 1993 Sep-Oct;39(5):635-40. doi: 10.1016/s0016-5107(93)70214-x.PMID: 8224684 Clinical Trial.

VIRAL HEPATITIS AND HCC

SlNo	Title
	I. VIRAL HEPATITIS AND HCC
1.	Kumar M, Kaur R, Kanthaje S, Dhiman RK, Chakraborti A. Bacterial metabolite butyrate in modulating sorafenib-targeted microRNAs to curtail its resistance in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2022 Dec 30. doi: 10.1007/s00432-022-04544-7. Online ahead of print.PMID: 36583742
2.	Katiyar H, Kamat M, Mandot AK, Goel A, Singh S, Mishra AK, Singh R, Tiwari P, Dhiman RK, Shah S.Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus Retreatment in Difficult-to-treat Patients: A Real-life Observational Study from India.J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101314. doi: 10.1016/j.jceh.2023.101314. Epub 2023 Dec 9.PMID: 38261859
3.	Mishra S, Taneja S, De A, Verma N, Premkumar M, Naidu GSRSNK, Sharma A, Duseja A, Dhiman RK, Singh V. Efficacy, Tolerability, and Compliance of Direct Acting Antivirals in Patients with HIV and Hepatitis C Coinfection: A Real-Life Experience. AIDS Res Hum Retroviruses. 2023 Jan 5. doi: 10.1089/AID.2022.0034. Online ahead of print.PMID: 36511384
4.	Kaur R, Kanthaje S, Taneja S, Dhiman RK, Chakraborti A. miR-23b-3p Modulating Cytoprotective Autophagy and Glutamine Addiction in Sorafenib Resistant HepG2, a Hepatocellular Carcinoma Cell Line. Genes (Basel). 2022 Aug 1;13(8):1375. doi: 10.3390/genes13081375.PMID: 36011286 Free PMC article.
5.	Kaur H, Dhiman RK, Kulkarni AV, Premkumar M, Singh V, Duseja AK, Grover S, Grover GS, Roy A, Verma N, De A, Taneja S, Mehtani R, Mishra S, Kaur H. Improvement of chronic HCV infection-related depression, anxiety, and neurocognitive performance in persons achieving SVR-12: A real-world cohort study. J Viral Hepat. 2022 May;29(5):395-406. doi: 10.1111/jvh.13668. Epub 2022 Mar 17.PMID: 35266624
6.	Tohra S, Duseja A, Taneja S, Kalra N, Gorsi U, Behera A, Kaman L, Dahiya D, Sahu S, Sharma B, Singh V, Dhiman RK, Chawla Y. Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis.J Clin Exp Hepatol. 2021 Nov-Dec;11(6):682-690. doi: 10.1016/j.jceh.2021.02.002. Epub 2021 Feb 11.PMID: 34866847 Free PMC article.
7.	Dhiman RK, Grover GS, Premkumar M, Roy A, Taneja S, Duseja A, Arora S; MMPHCRF Investigators. Outcomes of Real-World Integrated HCV Microelimination for People Who Inject Drugs: An expansion of the Punjab Model. EClinicalMedicine. 2021 Oct 17;41:101148. doi: 10.1016/j.eclinm.2021.101148. eCollection 2021 Nov.PMID: 34712928 Free PMC article.
8.	Rathi S, Duseja A, Thakur V, Ratho RK, Singh MP, Taneja S, Das A, Aggarwal R, Dhiman RK, Chawla YK. Chronic Hepatitis E With Genotype 1-Masquerading as Allograft Rejection After LiverTransplantation. J Clin Exp Hepatol. 2021 May-Jun;11(3):400-403. doi: 10.1016/j.jceh.2020.07.006. Epub 2020 Jul 18.PMID: 33994721 Free PMC article.
9.	Kalra N, Gupta P, Jugpal T, Naik SS, Gorsi U, Chaluvashetty SB, Bhujade H, Duseja A, Singh V, Dhiman RK, Sandhu MS. Percutaneous Cryoablation of Liver Tumors: Initial Experience from a Tertiary Care Center in India. J Clin Exp Hepatol. 2021 May-Jun;11(3):305-311. doi: 10.1016/j.jceh.2020.10.005. Epub 2020 Oct 19.PMID: 33994713 Free PMC article.
10.	Roy A, Dhiman RK. Letter to the Editor: Recurrent Cryoglobulinemic Vasculitis in the Era of Direct-Acting Antivirals: A Story Beyond Sustained Virological Response 12. Hepatology. 2021 Nov;74(5):2909. doi: 10.1002/hep.31860. Epub 2021 Aug 30.PMID: 33884650 No abstract available.
11.	Kapur S, Kalra N, Bhatia A, Duseja A, Das A, Dhiman RK, Chawla Y, Sandhu MS. Comparison of Elastography Point Quantification with Transient Elastography in Patients with Chronic Viral Hepatitis and Nonalcoholic Fatty Liver Disease: A Pilot Study. J Clin Exp Hepatol. 2021 Jan-Feb;11(1):21-29. doi: 10.1016/j.jceh.2020.06.005. Epub 2020 Jul 2.PMID: 33679045 Free PMC article.
12.	Chugh Y, Premkumar M, Grover GS, Dhiman RK, Teerawattananon Y, PrinjaS.Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India. BMJ Open. 2021 Feb 15;11(2):e042280. doi: 10.1136/bmjopen-2020-042280.PMID: 33589457 Free PMC article.
13.	Dhiman RK, Premkumar M. Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable. Clin Liver Dis (Hoboken). 2021 Jan 13;16(6):254-261. doi: 10.1002/cld.978. eCollection 2020 Dec.PMID: 33489098 Free PMC article. Review. No abstract available.
14.	Taneja S, Duseja A, Mehta M, De A, Verma N, Premkumar M, Dhiman RK, Singh V, Singh MP, Ratho RK, Ramachandran R, Kumar V, Kohli HS. Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end-stage renal disease on maintenance haemodialysis. Liver Int. 2021 Apr;41(4):705-709. doi: 10.1111/liv.14685.PMID: 33025685
15.	Kataruka M, Gupta S, Ramchandran R, Singh M, Dhiman RK, Lal Gupta K. Incidence and Risk Factors for Hepatitis C Virus and Hepatitis B Virus Seroconversion in End-Stage Renal Failure Patients on Maintenance Hemodialysis. J Clin Exp Hepatol. 2020 Jul-Aug;10(4):316-321. doi: 10.1016/j.jceh.2019.11.002. Epub 2019 Nov 27.PMID: 32655234 Free PMC article.
16.	Krishan S, Dhiman RK, Kalra N, Sharma R, Baijal SS, Arora A, Gulati A, Eapan A, Verma A, Keshava S, Mukund A, Deva S, Chaudhary R, Ganesan K, Taneja S, Gorsi U, Gamanagatti S, Madhusudan KS, Puri P, Shalimar, Govil S, Wadhavan M, Saigal S, Kumar A, Thapar S, Duseja A, Saraf N, Khandelwal A, Mukhopadyay S, Gulati A, Shetty N, Verma N. Corrigendum to "Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System" [J Clin Expt Hepatol 9 (2019) 625-651]. J Clin Exp Hepatol. 2020 Mar-Apr;10(2):188. doi: 10.1016/j.jceh.2020.02.004. Epub 2020 Mar 12.PMID: 32189936 Free PMC article.
17.	Kumar A, Acharya SK, Singh SP, Arora A, Dhiman RK, Aggarwal R, Anand AC, Bhangui P, Chawla YK, Datta Gupta S, Dixit VK, Duseja A, Kalra N, Kar P, Kulkarni SS, Kumar R, Kumar M, Madhavan R, Mohan Prasad VG, Mukund A, Nagral A, Panda D, Paul SB, Rao PN, Rela M, Sahu MK, Saraswat VA, Shah SR, Shalimar, Sharma P, Taneja S, Wadhawan M; INASL Task-Force on Hepatocellular Carcinoma. 2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations. J Clin Exp Hepatol. 2020 Jan-Feb;10(1):43-80. doi: 10.1016/j.jceh.2019.09.007. Epub 2019 Sep 23.PMID: 32025166 Free PMC article. Review.
18.	Bahuguna P, Prinja S, Lahariya C, Dhiman RK, Kumar MP, Sharma V, Aggarwal AK, Bhaskar R, De Graeve H, Bekedam H. Cost-Effectiveness of Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities in India.Appl Health Econ Health Policy. 2020 Jun;18(3):393-411. doi: 10.1007/s40258-019-00536-w.PMID: 31741306 Free PMC article.
19.	Krishan S, Dhiman RK, Kalra N, Sharma R, Baijal SS, Arora A, Gulati A, Eapan A, Verma A, Keshava S, Mukund A, Deva S, Chaudhary R, Ganesan K, Taneja S, Gorsi U, Gamanagatti S, Madhusudan KS, Puri P, Shalimar, Govil S, Wadhavan M, Saigal S, Kumar A, Thapar S, Duseja A, Saraf N, Khandelwal A, Mukhopadyay S, Gulati A, Shetty N, Verma N. Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System. J Clin Exp Hepatol. 2019 Sep-Oct;9(5):625-651. doi: 10.1016/j.jceh.2019.07.005. Epub 2019 Aug 6.PMID: 31695253 Free PMC article. Review.
20.	Gupta N, Verma RK, Prinja S, Dhiman RK. Cost-effectiveness of Sorafenib for Treatment of Advanced Hepatocellular Carcinoma in India.J Clin Exp Hepatol. 2019 Jul-Aug;9(4):468-475. doi: 10.1016/j.jceh.2018.10.003. Epub 2018 Oct 31.PMID: 31516263 Free PMC article.
21.	Chugh Y, Dhiman RK, Premkumar M, Prinja S, Singh Grover G, Bahuguna P. Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India.PLoS One. 2019 Aug 29;14(8):e0221769. doi: 10.1371/journal.pone.0221769. eCollection 2019.PMID: 31465503 Free PMC article.
22.	Bhasker B, Sachdev S, Marwaha N, Grover S, Singh T, Dhiman RK. Knowledge and Attitude Regarding Hepatitis B and C Among Blood Donors and Nondonors in North India. J Clin Exp Hepatol. 2019 May-Jun;9(3):318-323. doi: 10.1016/j.jceh.2018.08.005. Epub 2018 Aug 25.PMID: 31360024 Free PMC article.
23.	Dhiman RK, Grover GS, Premkumar M, Taneja S, Duseja A, Arora S, Rathi S, Satsangi S, Roy A; MMPHCRF Investigators. Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting. J Hepatol. 2019 Dec;71(6):1076-1085. doi: 10.1016/j.jhep.2019.07.006. Epub 2019 Jul 17.PMID: 31325468 Clinical Trial.
24.	Dhiman RK, Grover GS, Premkumar M. Hepatitis C elimination: a Public Health Perspective. Curr Treat Options Gastroenterol. 2019 Sep;17(3):367-377. doi: 10.1007/s11938-019-00240-7.PMID: 31321673 Review.
25.	Sahu SK, Chawla YK, Dhiman RK, Singh V, Duseja A, Taneja S, Kalra N, Gorsi U. Rupture of Hepatocellular Carcinoma: A Review of Literature. J Clin Exp Hepatol. 2019 Mar-Apr;9(2):245-256. doi: 10.1016/j.jceh.2018.04.002. Epub 2018 Apr 26.PMID: 31024207 Free PMC article. Review.
26.	Kalra N, Gupta P, Gorsi U, Bhujade H, Chaluvashetty SB, Duseja A, Singh V, Dhiman RK, Chawla YK, Khandelwal N. Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience. Cardiovasc InterventRadiol. 2019 Apr;42(4):584-590. doi: 10.1007/s00270-019-02164-2. Epub 2019 Jan 29.PMID: 30697637
27.	Arora A, Anand AC, Kumar A, Singh SP, Aggarwal R, Dhiman RK, Aggarwal S, Alam S, Bhaumik P, Dixit VK, Goel A, Goswami B, Kumar A, Kumar M, Madan K, Murugan N, Nagral A, Puri AS, Rao PN, Saraf N, Saraswat VA, Sehgal S, Sharma P, Shenoy KT, Wadhawan M; Members of the INASL taskforce on Hepatitis B. INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids. J Clin Exp Hepatol. 2018 Dec;8(4):403-431. doi: 10.1016/j.jceh.2018.06.010. Epub 2018 Jun 26.PMID: 30568345 Free PMC article.
28.	Dhiman RK, Grover GS, Premkumar M, Taneja S, Duseja A, Rathi S, Satsangi S. Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective. J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):74-80. doi: 10.1097/MPG.0000000000002139.PMID: 30211847
29.	Arora A, Singh SP, Kumar A, Saraswat VA, Aggarwal R, Bangar M, Bhaumik P, Devarbhavi H, Dhiman RK, Dixit VK, Goel A, Goswami B, Kapoor D, Madan K, Narayan J, Nijhawan S, Pandey G, Rai RR, Sahu MK, Saraf N, Shalimar, Shenoy T, Thomas V, Wadhawan M; INASL Hepatitis B Taskforce. INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements. J Clin Exp Hepatol. 2018 Mar;8(1):58-80. doi: 10.1016/j.jceh.2017.12.001. Epub 2017 Dec 16.PMID: 29743798 Free PMC article. Review.
30.	Premkumar M, Dhiman RK. Direct-Acting Antiviral Agents for HCV Infection. J Clin Exp Hepatol. 2018 Mar;8(1):1-2. doi: 10.1016/j.jceh.2018.01.002. Epub 2018 Mar 26.PMID: 29743789 Free PMC article. No abstract available.
31.	Kalra N, Kang M, Duseja AK, Bhatia A, Singh V, Dhiman RK, Rajwanshi A, Chawla YK, Khandelwal N. Comparison of radiofrequency ablation alone & in combination with percutaneous ethanol injection for management of hepatocellular carcinoma. Indian J Med Res. 2017 Nov;146(Suppl):S30-S37. doi: 10.4103/ijmr.IJMR_1812_15.PMID: 29578192 Free PMC article.
32.	Taneja S, Duseja A, De A, Mehta M, Ramachandran R, Kumar V, Kohli HS, Gupta KL, Dhiman RK, Chawla Y. Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease. Dig Dis Sci. 2018 May;63(5):1334-1340. doi: 10.1007/s10620-018-4979-6. Epub 2018 Feb 26.PMID: 29484572
33.	Sahu SK, Taneja S, Kalra N, Dhiman RK, Chawla YK, Duseja A, Singh V. Rupture of Hepatocellular Carcinoma: a Tale of 20 Cases from a Tertiary Care Center in Northern India. J Gastrointest Cancer. 2019 Sep;50(3):596-600. doi: 10.1007/s12029-018-0063-x.PMID: 29399732 No abstract available.
34.	Makol A, Kanthaje S, Dhiman RK, Kalra N, Chawla YK, Chakraborti A. Association of liver cirrhosis severity with type 2 diabetes mellitus in hepatocellular carcinoma. Exp Biol Med (Maywood). 2018 Feb;243(4):323-326. doi: 10.1177/1535370217744511. Epub 2017 Nov 29.PMID: 29186978 Free PMC article.
35.	Puri P, Saraswat VA, Dhiman RK, Anand AC, Acharya SK, Singh SP, Chawla YK, Amarapurkar DN, Kumar A, Arora A, Dixit VK, Koshy A, Sood A, Duseja A, Kapoor D, Madan K, Srivastava A, Kumar A, Wadhawan M, Goel A, Verma A, Shalimar, Pandey G, Malik R, Agrawal S. Corrigendum to "Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016" [J. Clin. Exp. Hepatol. 6 (2016) 119-145]. J Clin Exp Hepatol. 2016 Sep;6(3):263. doi: 10.1016/j.jceh.2016.09.009. Epub 2016 Oct 3.PMID: 29021664 Free PMC article.
36.	Premkumar M, Grover GS, Dhiman RK. Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs? J Clin Exp Hepatol. 2017 Sep;7(3):253-261. doi: 10.1016/j.jceh.2017.08.003. Epub 2017 Sep 23.PMID: 28970713 Free PMC article. Review.
37.	Moudgil S, Kalra N, Prabhakar N, Dhiman RK, Behera A, Chawla YK, Khandelwal N. Comparison of Contrast Enhanced Ultrasound With Contrast Enhanced Computed Tomography for the Diagnosis of Hepatocellular Carcinoma. J Clin Exp Hepatol. 2017 Sep;7(3):222-229. doi: 10.1016/j.jceh.2017.03.003. Epub 2017 Mar 16.PMID: 28970709 Free PMC article.
38.	Taneja S, Duseja A, De A, Kumar V, Ramachandran R, Sharma A, Dhiman RK, Gupta KL, Chawla Y. Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients. Nephrology (Carlton). 2018 Sep;23(9):876-882. doi: 10.1111/nep.13109.PMID: 28703905
39.	Shankar S, Kalra N, Bhatia A, Srinivasan R, Singh P, Dhiman RK, Khandelwal N, Chawla Y. Role of Diffusion Weighted Imaging (DWI) for Hepatocellular Carcinoma (HCC) Detection and its Grading on 3T MRI: A Prospective Study. J Clin Exp Hepatol. 2016 Dec;6(4):303-310. doi: 10.1016/j.jceh.2016.08.012. Epub 2016 Sep 1.PMID: 28003720 Free PMC article.
40.	Taneja S, Tohra S, Duseja A, Dhiman RK, Chawla YK. Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital. J Clin Exp Hepatol. 2016 Dec;6(4):282-290. doi: 10.1016/j.jceh.2016.08.001. Epub 2016 Aug 18.PMID: 28003717 Free PMC article.
41.	Satsangi S, Dhiman RK. Combating the wrath of viral hepatitis in India. Indian J Med Res. 2016 Jul;144(1):1-5. doi: 10.4103/0971-5916.193275.PMID: 27834318 Free PMC article. No abstract available.
42.	Dhiman RK, Satsangi S, Grover GS, Puri P. Tackling the Hepatitis C Disease Burden in Punjab, India. J Clin Exp Hepatol. 2016 Sep;6(3):224-232. doi: 10.1016/j.jceh.2016.09.005. Epub 2016 Sep 7.PMID: 27746619 Free PMC article. Review.
43.	Satsangi S, Mehta M, Duseja A, Taneja S, Dhiman RK, Chawla Y. Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C. J Gastroenterol Hepatol. 2017 Apr;32(4):859-863. doi: 10.1111/jgh.13595.PMID: 27624314
44.	Puri P, Saraswat VA, Dhiman RK, Anand AC, Acharya SK, Singh SP, Chawla YK, Amarapurkar DN, Kumar A, Arora A, Dixit VK, Koshy A, Sood A, Duseja A, Kapoor D, Madan K, Srivastava A, Kumar A, Wadhawan M, Goel A, Verma A, Shalimar, Pandey G, Malik R, Agrawal S. Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016. J Clin Exp Hepatol. 2016 Jun;6(2):119-45. doi: 10.1016/j.jceh.2016.07.001. Epub 2016 Jul 2.PMID: 27493460 Free PMC article. Review.
45.	Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Sarin SK, Singh SP, Chawla YK, Aggarwal R, Amarapurkar D, Arora A, Dixit VK, Sood A, Shah S, Duseja A, Kapoor D, Shalimar, Madan K, Pande G, Nagral A, Kar P, Koshy A, Puri AS, Eapen CE, Thareja S. Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015. J Clin Exp Hepatol. 2015 Sep;5(3):221-38. doi: 10.1016/j.jceh.2015.09.002. Epub 2015 Sep 21.PMID: 26628840 Free PMC article. Review.
46.	Singla B, Bhattacharyya R, Chakraborti A, Sharma BK, Kapil S, Chawla YK, Arora SK, Das A, Dhiman RK, Duseja A. Response to potent anti-HBV agents in chronic hepatitis B and combined effect of HBV reverse transcriptase mutations. Gene. 2015 Aug 1;567(1):22-30. doi: 10.1016/j.gene.2015.04.060. Epub 2015 Apr 24.PMID: 25917965
47.	Rathor M, Lal A, Dhiman RK. Spontaneous rupture of hepatocellular carcinoma. J Clin Exp Hepatol. 2014 Jun;4(2):188-9. doi: 10.1016/j.jceh.2014.06.003. Epub 2014 Jun 20.PMID: 25755559 Free PMC article. No abstract available.
48.	Puri P, Anand AC, Saraswat VA, Acharya SK, Sarin SK, Dhiman RK, Aggarwal R, Singh SP, Amarapurkar D, Arora A, Chhabra M, Chetri K, Choudhuri G, Dixit VK, Duseja A, Jain AK, Kapoor D, Kar P, Koshy A, Kumar A, Madan K, Misra SP, Prasad MV, Nagral A, Puri AS, Jeyamani R, Saigal S, Shah S, Sharma PK, Sood A, Thareja S, Wadhawan M. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India. J Clin Exp Hepatol. 2014 Jun;4(2):117-40. doi: 10.1016/j.jceh.2014.06.001. Epub 2014 Jun 24.PMID: 25755549 Free PMC article. Review.
49.	Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Aggarwal R, Singh SP, Amarapurkar D, Arora A, Chhabra M, Chetri K, Choudhuri G, Dixit VK, Duseja A, Jain AK, Kapoorz D, Kar P, Koshy A, Kumar A, Madan K, Misra SP, Prasad MV, Nagral A, Puri AS, Jeyamani R, Saigal S, Sarin SK, Shah S, Sharma PK, Sood A, Thareja S, Wadhawan M. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India. J Clin Exp Hepatol. 2014 Jun;4(2):106-16. doi: 10.1016/j.jceh.2014.05.006. Epub 2014 Jun 9.PMID: 25755548 Free PMC article. Review.
50.	Dhiman RK. Future of therapy for Hepatitis C in India: A Matter of Accessibility and Affordability? J Clin Exp Hepatol. 2014 Jun;4(2):85-6. doi: 10.1016/j.jceh.2014.06.011.PMID: 25755543 Free PMC article. No abstract available.
51.	Kanwar AJ, Vinay K, Heelan K, Walsh S, Shear NH, Dhiman RK. Use of rituximab in pemphigus patients with chronic viral hepatitis: report of three cases. Indian J Dermatol VenereolLeprol. 2014 Sep-Oct;80(5):422-6. doi: 10.4103/0378-6323.140301.PMID: 25201843 Free article.
52.	Singla B, Chakraborti A, Sharma BK, Kapil S, Chawla YK, Arora SK, Das A, Dhiman RK, Duseja A. Levels of hepatitis B virus replicative intermediate in serum samples of chronic hepatitis B patients. Mol Biol Rep. 2014 Jul;41(7):4689-96. doi: 10.1007/s11033-014-3339-7. Epub 2014 Apr 6.PMID: 24706057
53.	Kalra N, Kang M, Bhatia A, Duseja AK, Dhiman RK, Arya VK, Rajwanshi A, Chawla YK, Khandelwal N. Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience. Indian J Radiol Imaging. 2013 Apr;23(2):139-44. doi: 10.4103/0971-3026.116569.PMID: 24082478 Free PMC article.
54.	Sharma BK, Srinivasan R, Kapil S, Singla B, Chawla YK, Chakraborti A, Saini N, Duseja A, Das A, Kalra N, Dhiman RK. Angiogenic and anti-angiogenic factor gene transcript level quantitation by quantitative real time PCR in patients with hepatocellular carcinoma. Mol Biol Rep. 2013 Oct;40(10):5843-52. doi: 10.1007/s11033-013-2690-4. Epub 2013 Sep 22.PMID: 24057240
55.	Singla B, Chakraborti A, Sharma BK, Kapil S, Chawla YK, Arora SK, Das A, Dhiman RK, Duseja A. Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients. J Med Virol. 2013 Jul;85(7):1155-62. doi: 10.1002/jmv.23608.PMID: 23918533
56.	Sharma BK, Srinivasan R, Kapil S, Singla B, Saini N, Chawla YK, Chakraborti A, Duseja A, Kalra N, Dhiman RK. Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma. Mol Cell Biochem. 2013 Nov;383(1-2):103-12. doi: 10.1007/s11010-013-1759-7. Epub 2013 Aug 4.PMID: 23912396
57.	Duseja A, Choudhary NS, Gupta S, Dhiman RK, Chawla Y, Sakhuja V. Treatment of chronic hepatitis C in end stage renal disease: experience at a tertiary care centre. Trop Gastroenterol. 2012 Jul-Sep;33(3):189-92. doi: 10.7869/tg.2012.47.PMID: 23600049
58.	Vasishta R, Kakkar N, Duseja AK, Dhiman RK. Fatal hepatitis C in a renal transplant recipient on immunosuppression. J Clin Exp Hepatol. 2012 Jun;2(2):191-2. doi: 10.1016/S0973-6883(12)60109-1. Epub 2012 Jul 21.PMID: 25755428 Free PMC article. No abstract available.
59.	Ghosh S, Duseja A, Dhiman RK, Chawla YK. Tongue hyperpigmentation resulting from peginterferon alfa-2b and ribavirin treatment in a patient with chronic hepatitis C. Dig Dis Sci. 2012 Mar;57(3):820-1. doi: 10.1007/s10620-011-1914-5. Epub 2011 Sep 24.PMID: 21948358
60.	Dhiman RK, Kalra N, Vasishta RK, Singh R, Chawla Y. Biliary obstruction and a mass lesion in the liver. J Clin Exp Hepatol. 2011 Sep;1(2):121. doi: 10.1016/S0973-6883(11)60133-3. Epub 2011 Nov 9.PMID: 25755325 Free PMC article. No abstract available.
61.	Varma S, Kumar S, Garg A, Malhotra P, Das A, Sharma A, Chawla YK, Dhiman RK. Hepatitis C virus infection among patients with chronic immune thrombocytopenic purpura in northern India. J Clin Exp Hepatol. 2011 Sep;1(2):68-72. doi: 10.1016/S0973-6883(11)60124-2. Epub 2011 Nov 9.PMID: 25755317 Free PMC article.
62.	Tohra SK, Taneja S, Ghosh S, Sharma BK, Duseja A, Dhiman RK, Das A, Chawla YK. Prediction of sustained virological response to combination therapy with pegylated interferon alfa and ribavirin in patients with genotype 3 chronic hepatitis C. Dig Dis Sci. 2011 Aug;56(8):2449-55. doi: 10.1007/s10620-011-1770-3. Epub 2011 Jun 25.PMID: 21706207
63.	Garg A, Reddy C, Duseja A, Chawla Y, Dhiman RK. Association between Celiac Disease and Chronic Hepatitis C Virus Infection. J Clin Exp Hepatol. 2011 Jun;1(1):41-4. doi: 10.1016/S0973-6883(11)60116-3. Epub 2011 Aug 26.PMID: 25755310 Free PMC article.
64.	Sarma S, Sharma B, Chawla YK, Kapil S, Singla B, Kalra N, Behera A, Duseja A, Dhiman RK. Comparison of 7 staging systems in north Indian cohort of hepatocellular carcinoma. Trop Gastroenterol. 2010 Oct-Dec;31(4):271-8.PMID: 21568142
65.	Varma S, Menon MC, Garg A, Malhotra P, Sharma A, Chawla YK, Dhiman RK. Hepatitis C virus infection among patients with non-Hodgkin's lymphoma in northern India. Hepatol Int. 2011 Jun;5(2):688-92. doi: 10.1007/s12072-010-9244-9. Epub 2011 Jan 30.PMID: 21484139 Free PMC article.
66.	Sharma B, Srinivasan R, Chawla YK, Kapil S, Saini N, Singla B, Chakraborthy A, Kalra N, Duseja A, Dhiman RK. Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population. Hepatol Int. 2010 Jul 13;4(3):569-76. doi: 10.1007/s12072-010-9186-2.PMID: 21063479 Free PMC article.
67.	Sharma S, Sharma B, Singla B, Chawla YK, Chakraborti A, Saini N, Duseja A, Das A, Dhiman RK. Clinical significance of genotypes and precore/basal core promoter mutations in HBV related chronic liver disease patients in North India. Dig Dis Sci. 2010 Mar;55(3):794-802. doi: 10.1007/s10620-009-1083-y. Epub 2009 Dec 31.PMID: 20043209
68.	Sharma A, Chakraborti A, Das A, Dhiman RK, Chawla Y. Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis. Immunology. 2009 Sep;128(1 Suppl):e514-22. doi: 10.1111/j.1365-2567.2008.03021.x.Epub 2008 Nov 24.PMID: 19740312 Free PMC article.
69.	Duseja A, Dhiman RK, Chawla Y, Thumburu KK, Kumar A, Das A, Bhadada S, Bhansali A. Insulin resistance is common in patients with predominantly genotype 3 chronic hepatitis C. Dig Dis Sci. 2009 Aug;54(8):1778-82. doi: 10.1007/s10620-009-0844-y. Epub 2009 Jun 10.PMID: 19513842
70.	Bali S, Kar SS, Kumar S, Ratho RK, Dhiman RK, Kumar R. Hepatitis E epidemic with bimodal peak in a town of north India. Indian J Public Health. 2008 Oct-Dec;52(4):189-93, 199.PMID: 19189818
71.	Duseja A, Sharma S, Das K, Dhiman RK, Chawla YK. Is vaccination against hepatitis A virus required in patients with cirrhosis of the liver? Trop Gastroenterol. 2004 Oct-Dec;25(4):162-3.PMID: 15912973
72.	Dhiman RK, Chawla Y. Acute viral hepatitis C should be treated. Indian J Gastroenterol. 2005 Mar-Apr;24(2):68-71.PMID: 15879654 No abstract available.
73.	Varma S, Dhiman RK, Srivastava D, Malhotra P, Chawla Y. Absence of hepatitis C virus infection among patients with lymphoproliferative disorders in northern India. Gastroenterology. 2004 May;126(5):1498-9; author reply 1499. doi: 10.1053/j.gastro.2004.03.045.PMID: 15131829 No abstract available.
74.	Jain AK, Sukhija J, Saini JS, Chawla Y, Dhiman RK. Hepatitis C virus-associated keratitis. Eye (Lond). 2004 Feb;18(2):131-4. doi: 10.1038/sj.eye.6700604.PMID: 14762402
75.	Duseja A, Arora L, Masih B, Singh H, Gupta A, Behera D, Chawla YK, Dhiman RK. Hepatitis B and C virus--prevalence and prevention in health care workers. Trop Gastroenterol. 2002 Jul-Sep;23(3):125-6.PMID: 12693154
76.	Sharma RR, Dhiman RK, Chawla Y, Vasistha RK. Immunohistochemistry for core and surface antigens in chronic hepatitis. Trop Gastroenterol. 2002 Jan-Mar;23(1):16-9.PMID: 12170914
77.	Sud A, Singh J, Dhiman RK, Wanchu A, Singh S, Chawla Y. Hepatitis B virus co-infection in HIV infected patients. Trop Gastroenterol. 2001 Apr-Jun;22(2):90-2.PMID: 11552493
78.	Shankar KR, Dhiman RK, Narang A. Immunogenicity of plasma-derived hepatitis B vaccine in preterm infants. Indian J Pediatr. 2000 Jan;67(1):23-6. doi: 10.1007/BF02802630.PMID: 10832216 Clinical Trial.
79.	Dhiman RK, Kohli HS, Das G, Joshi K, Chawla Y, Sakhuja V. Remission of HBV-related mesangioproliferative glomerulonephritis after interferon therapy. Nephrol Dial Transplant. 1999 Jan;14(1):176-8. doi: 10.1093/ndt/14.1.176.PMID: 10052500 No abstract available.
80.	Sawhney IM, Verma PK, Dhiman RK, Chopra JS, Sharma A, Chawla YK, Dilawari JB. Visual and auditory evoked responses in acute severe hepatitis. J Gastroenterol Hepatol. 1997 Jul;12(7):554-9. doi: 10.1111/j.1440-1746.1997.tb00484.x.PMID: 9257251

ALF, ACLF AND ALCHOLIC HEPATITIS

SlNo	Title
	I. ALF, ACLF AND ALCHOLIC HEPATITIS
1.	Maiwall R, Pasupuleti SSR, Choudhury A, Kim DJ, Sood A, Goyal O, Midha V, Devarbhavi H, Arora A, Kumar A, Sahu MK, Maharshi S, Duseja AK, Singh V, Taneja S, Rao PN, Kulkarni A, Ghazinian H, Hamid S, Eapen CE, Goel A, Shreshtha A, Shah S, Hu J, Prasad VGM, Yuemin N, Shaojie X, Dhiman RK, Chen T, Ning Q, Panackel C, Niriella MA, Lama TK, Tan SS, Dokmeci AK, Shukla A, Sharma MK, Sarin SK. AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational study. Hepatol Int. 2023 Jun;17(3):662-675. doi: 10.1007/s12072-022-10463-z. Epub 2022 Dec 26.PMID: 36571711
2.	Kaur P, Verma N, Valsan A, Garg P, Rathi S, De A, Premkumar M, Taneja S, Duseja A, Singh V, Dhiman RK.Prevalence, Risk Factors, and Impact of Bacterial or Fungal Infections in Acute Liver Failure Patients from India. Dig Dis Sci. 2023 Oct;68(10):4022-4038. doi: 10.1007/s10620-023-07971-9. Epub 2023 Aug 14.PMID: 37578566
3.	Thanapirom K, Treeprasertsuk S, Choudhury A, Verma N, Dhiman RK, Al Mahtab M, Devarbhavi H, Shukla A, Hamid SS, Jafri W, Tan SS, Lee GH, Ghazinyan H, Sood A, Kim DJ, Eapen CE, Tao H, Yuemin N, Dokmeci AK, Sahu M, Arora A, Kumar A, Kumar R, Prasad VGM, Shresta A, Sollano J, Payawal DA, Lau G, Sarin SK.Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patients.Sci Rep. 2024 Mar 9;14(1):5796. doi: 10.1038/s41598-024-56401-x.
4.	Sharma S, Agarwal S, Saraya A, Choudhury A, Mahtab MA, Alam MS, Saigal S, Kim DJ, Eapen CE, Goel A, Ning Q, Devarbhavi H, Singh V, Shukla A, Hamid S, Hu J, Tan SS, Arora A, Sahu MK, Rela M, Jothimani D, Rao PN, Kulkarni A, Ghaznian H, Lee GH, Zhongping D, Sood A, Goyal O, Lesmana LA, Lesmana RC, Treeprasertsuk S, Yuemin N, Shah S, Tao H, Dayal VM, Shaojie X, Karim F, Abbas Z, Sollano JD, Kalista KF, Shreshtha A, Payawal D, Omata M, Sarin SK; APASL ACLF Research Consortium (AARC) for APASL ACLF Working Party. Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC). Hepatol Int. 2022 Oct;16(5):1234-1243. doi: 10.1007/s12072-022-10372-1. Epub 2022 Jul 18.PMID: 35851437
5.	Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman RK, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwall R, Mohan N, Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M; INASL Task-Force on Acute Liver Failure. Erratum to 'Indian National Association for the Study of Liver Consensus Statement on Acute Liver Failure (Part-2): Management of Acute Liver Failure' [J Clin Exp Hepatol 10 (2020) 477-517]. J Clin Exp Hepatol. 2022 Mar-Apr;12(2):729-730. doi: 10.1016/j.jceh.2022.01.003. Epub 2022 Jan 11.PMID: 35535113 Free PMC article.
6.	Sharma A, Roy A, Premkumar M, Verma N, Duseja A, Taneja S, Grover S, Chopra M, Dhiman RK. Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial. Hepatol Int. 2022 Apr;16(2):433-446. doi: 10.1007/s12072-022-10312-z. Epub 2022 Mar 28.PMID: 35349076
7.	Thanapirom K, Teerasarntipan T, Treeprasertsuk S, Choudhury A, Sahu MK, Maiwall R, Pamecha V, Moreau R, Al Mahtab M, Chawla YK, Devarbhavi H, Yu C, Ning Q, Amarapurkar D, Eapen CE, Hamid SS, Butt AS, Kim DJ, Lee GH, Sood A, Lesmana LA, Abbas Z, Shiha G, Payawal DA, Yuen MF, Chan A, Lau G, Jia J, Rahman S, Sharma BC, Yokosuka O, Sarin SK; APASL ACLF Working Party. Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure.Hepatol Int. 2022 Feb;16(1):171-182. doi: 10.1007/s12072-021-10266-8. Epub 2021 Nov 25.PMID: 34822057
8.	Verma N, Dhiman RK, Singh V, Duseja A, Taneja S, Choudhury A, Sharma MK, Eapen CE, Devarbhavi H, Al Mahtab M, Shukla A, Hamid SS, Jafri W, Butt AS, Ning Q, Chen T, Tan SS, Lesmana LA, Lesmana CRA, Sahu MK, Hu J, Lee GH, Sood A, Midha V, Goyal O, Ghazinian H, Kim DJ, Treeprasertsuk S, Mohan Prasad VG, Dokmeci AK, Sollano JD, Shah S, Payawal DA, Rao PN, Kulkarni A, Lau GK, Duan Z, Chen Y, Yokosuka O, Abbas Z, Karim F, Chowdhury D, Prasad AS, Sarin SK; APASL ACLF Working Party. Comparative accuracy of prognostic models for short-term mortality in acute-on-chronic liver failure patients: CAP-ACLF.Hepatol Int. 2021 Jun;15(3):753-765. doi: 10.1007/s12072-021-10175-w. Epub 2021 Jun 25.PMID: 34173167
9.	Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman RK, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwall R, Mohan N, Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M; INASL Task-Force on Acute Liver Failure. Indian National Association for the Study of Liver Consensus Statement on Acute Liver Failure (Part-2): Management of Acute Liver Failure. J Clin Exp Hepatol. 2020 Sep-Oct;10(5):477-517. doi: 10.1016/j.jceh.2020.04.011. Epub 2020 Apr 22.PMID: 33029057 Free PMC article. Review.
10.	Duseja A, De A, Taneja S, Choudhury AK, Devarbhavi H, Hu J, Hamid SS, Butt AS, Jafri SMW, Ghazinian H, Chawla YK, Dhiman RK, Duan Z, Chen Y, Tan SS, Lee GH, Lim SG, Kim DJ, Sahu M, Sollano JD, Carpio G, Mohan Prasad VG, Abbas Z, Lesmana LA, Lesmana CR, Eapen CE, Goel A, Sood A, Midha V, Goyal O, Dokmeci AK, Ning Q, Chen T, Ma K, Payawal DA, Lau GKK, Al Mahtab M, Rahman S, Alam MS, Shukla A, Shrestha A, Shah S, Kalal CR, Kumar G, Jain P, Paulson I, Sarin SK; APASL ACLF Working Party, APASL ACLF Research Consortium (AARC). Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure.Liver Int. 2021 Jan;41(1):150-157. doi: 10.1111/liv.14671.PMID: 32970356
11.	Makkar K, Tomer S, Verma N, Rathi S, Arora SK, Taneja S, Duseja A, Chawla YK, Dhiman RK. Neutrophil dysfunction predicts 90-day survival in patients with acute on chronic liver failure: A longitudinal case-control study. JGH Open. 2020 May 5;4(4):595-602. doi: 10.1002/jgh3.12344. eCollection 2020 Aug.PMID: 32782944 Free PMC article.
12.	Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Rastogi A, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Alam S, Song DS, Yang JM, Yoon EL; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019 Nov;13(6):826-828. doi: 10.1007/s12072-019-09980-1. Epub 2019 Oct 9.PMID: 31595462 Free PMC article.
13.	Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Rastogi A, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Alam S, Song DS, Yang JM, Yoon EL; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019 Jul;13(4):353-390. doi: 10.1007/s12072-019-09946-3. Epub 2019 Jun 6.PMID: 31172417 Free PMC article.
14.	Devarbhavi H, Choudhury AK, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Chawla YK, Dhiman RK, Duseja A, Taneja S, Ning Q, Jia JD, Duan Z, Yu C, Eapen CE, Goel A, Tan SS, Hamid SS, Butt AS, Jafri W, Kim DJ, Hu J, Sood A, Midha V, Shukla A, Ghazinian H, Sahu MK, Treeprasertsuk S, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Kalal C, Abbas Z, Sollano JD, Prasad VGM, Payawal DA, Dokmeci AK, Rao PN, Shrestha A, Lau GK, Yuen MF, Saraswat VA, Shiha G, Yokosuka O, Kedarisetty CK, Jain P, Bhatia P, Sarin SK; APASL ACLF working party. Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients.Am J Gastroenterol. 2019 Jun;114(6):929-937. doi: 10.14309/ajg.0000000000000201.PMID: 31021832
15.	Verma N, Singh S, Taneja S, Duseja A, Singh V, Dhiman RK, Chakrabarti A, Chawla YK. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections. Liver Int. 2019 Mar;39(3):503-513. doi: 10.1111/liv.13981. Epub 2018 Oct 24.PMID: 30276951
16.	Satsangi S, Duseja A, Sachdeva M, Tomer S, Arora SK, Taneja S, Dhiman RK, Chawla YK. Monocyte human leukocyte antigen - Antigen D related, neutrophil oxidative burst and cytokine analysis in patients of decompensated cirrhosis with and without acute-on chronic liver failure.PLoS One. 2018 Jul 18;13(7):e0200644. doi: 10.1371/journal.pone.0200644. eCollection 2018.PMID: 30020985 Free PMC article.
17.	Agrawal S, Rana BS, Mitra S, Duseja A, Das A, Dhiman RK, Chawla Y. A Case of Acute-on-Chronic Liver Failure (ACLF) Due to An Uncommon Acute And Chronic Event. J Clin Exp Hepatol. 2018 Mar;8(1):95-97. doi: 10.1016/j.jceh.2017.08.006. Epub 2017 Sep 1.PMID: 29743800 Free PMC article.
18.	Verma N, Kumar P, Mitra S, Taneja S, Dhooria S, Das A, Duseja A, Dhiman RK, Chawla Y. Drug idiosyncrasy due to pirfenidone presenting as acute liver failure: Case report and mini-review of the literature. Hepatol Commun. 2017 Dec 27;2(2):142-147. doi: 10.1002/hep4.1133. eCollection 2018 Feb.PMID: 29404521 Free PMC article. Review.
19.	Gupta T, Dhiman RK, Ahuja CK, Agrawal S, Chopra M, Kalra N, Duseja A, Taneja S, Khandelwal N, Chawla Y. Characterization of Cerebral Edema in Acute-on-Chronic Liver Failure. J Clin Exp Hepatol. 2017 Sep;7(3):190-197. doi: 10.1016/j.jceh.2017.04.001. Epub 2017 Apr 8.PMID: 28970705 Free PMC article.
20.	Taneja S, Kumar P, Rathi S, Duseja A, Singh V, Dhiman RK, Chawla YK. Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment. Ann Hepatol. 2017 Sep-Oct;16(5):818-821. doi: 10.5604/01.3001.0010.2829.PMID: 28809737 Free article.
21.	Verma N, Sharma M, Biswal M, Taneja S, Batra N, Kumar A, Dhiman RK. Hepatitis E Virus Induced Acute Liver Failure with Scrub Typhus Coinfection in a Pregnant Woman. J Clin Exp Hepatol. 2017 Jun;7(2):158-160. doi: 10.1016/j.jceh.2016.09.015. Epub 2016 Oct 7.PMID: 28663682 Free PMC article.
22.	Gupta T, Dhiman RK, Rathi S, Agrawal S, Duseja A, Taneja S, Chawla Y. Impact of Hepatic and Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure. J Clin Exp Hepatol. 2017 Mar;7(1):9-15. doi: 10.1016/j.jceh.2016.10.006. Epub 2016 Oct 29.PMID: 28348465 Free PMC article.
23.	Shalimar; Saraswat V, Singh SP, Duseja A, Shukla A, Eapen CE, Kumar D, Pandey G, Venkataraman J, Puri P, Narayanswami K, Dhiman RK, Thareja S, Nijhawan S, Bhatia S, Zachariah U, Sonika U, Varghese T, Acharya SK. Acute-on-chronic liver failure in India: The Indian National Association for Study of the Liver consortium experience. J Gastroenterol Hepatol. 2016 Oct;31(10):1742-1749. doi: 10.1111/jgh.13340.PMID: 26989861
24.	Anand AC, Dhiman RK. Acute on Chronic Liver Failure-What is in a 'Definition'? J Clin Exp Hepatol. 2016 Sep;6(3):233-240. doi: 10.1016/j.jceh.2016.08.011. Epub 2016 Sep 1.PMID: 27746620 Free PMC article. Review.
25.	Taneja S, Borakokty A, Duseja A, Dhiman RK, Chawla Y. Acute Liver Failure Caused by Hepatitis A Virus with Dengue Coinfection. J Clin Exp Hepatol. 2016 Jun;6(2):164. doi: 10.1016/j.jceh.2016.01.006. Epub 2016 Feb 1.PMID: 27493466 Free PMC article. No abstract available.
26.	Bodh V, Kalra N, Dhiman RK. Pseudoparallel channel sign on ultrasonography in alcoholic hepatitis. J Clin Exp Hepatol. 2014 Mar;4(1):68-70. doi: 10.1016/j.jceh.2014.04.002. Epub 2014 Apr 21.PMID: 25755538 Free PMC article. No abstract available.
27.	Dhiman RK, Agrawal S, Gupta T, Duseja A, Chawla Y. Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome. World J Gastroenterol. 2014 Oct 28;20(40):14934-41. doi: 10.3748/wjg.v20.i40.14934.PMID: 25356054 Free PMC article.
28.	Agrawal S, Duseja A, Gupta T, Dhiman RK, Chawla Y. Simple organ failure count versus CANONIC grading system for predicting mortality in acute-on-chronic liver failure. J Gastroenterol Hepatol. 2015 Mar;30(3):575-81. doi: 10.1111/jgh.12778.PMID: 25251968
29.	Dhiman RK. Biomimetic enzyme nanocomplexes: use as antidotes and preventive measures for alcohol intoxication. J Clin Exp Hepatol. 2013 Dec;3(4):273-4. doi: 10.1016/j.jceh.2013.12.004.PMID: 25755513 Free PMC article. No abstract available.
30.	Duseja A, Choudhary NS, Gupta S, Dhiman RK, Chawla Y. APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF). J Dig Dis. 2013 Sep;14(9):484-90. doi: 10.1111/1751-2980.12074.PMID: 23692973
31.	Choudhary NS, Duseja A, Kalra N, Das A, Dhiman RK, Chawla YK. Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol. 2012 Jul-Aug;11(4):478-86.PMID: 22700629 Free article.
32.	Thumburu KK, Taneja S, Vasishta RK, Dhiman RK. Neuropathology of acute liver failure. Neurochem Int. 2012 Jun;60(7):672-5. doi: 10.1016/j.neuint.2011.10.013. Epub 2011 Dec 16.PMID: 22198438 Review.
33.	Choudhary N, Dhiman R, Bhalla A, Sharma N, Duseja A, Chawla Y. 5 comparison of clinical prognostic indicators (CPI) with model for end-stage liver disease (MELD) and king's college hospital (KCH) criteria for mortality prediction in acute liver failure. J Clin Exp Hepatol. 2011 Sep;1(2):135. doi: 10.1016/S0973-6883(11)60142-4.PMID: 25755335 Free PMC article. No abstract available.
34.	Duseja A, Chawla YK, Dhiman RK, Kumar A, Choudhary N, Taneja S. Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure (ACLF). Dig Dis Sci. 2010 Nov;55(11):3188-92. doi: 10.1007/s10620-010-1377-0. Epub 2010 Aug 19.PMID: 20721624
35.	Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, Duseja A, Chawla Y. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria. Liver Transpl. 2007 Jun;13(6):814-21. doi: 10.1002/lt.21050.PMID: 17370333 Free article.
36.	Chawla Y, Sreedharan A, Dhiman RK, Jain S, Suri S. Portal hemodynamics in fulminant hepatic failure as assessed by duplex Doppler ultrasonography. Dig Dis Sci. 2001 Mar;46(3):504-8. doi: 10.1023/a:1005634812578.PMID: 11318523
37.	Dhiman RK, Makharia GK, Jain S, Chawla Y. Ascites and spontaneous bacterial peritonitis in fulminant hepatic failure. Am J Gastroenterol. 2000 Jan;95(1):233-8. doi: 10.1111/j.1572-0241.2000.01691.x.PMID: 10638590
38.	Poddar U, Chawla Y, Dhiman RK, Vaiphei K, Vasishta RK, Dilawari JB. Spontaneous bacterial peritonitis in fulminant hepatic failure. J Gastroenterol Hepatol. 1998 Jan;13(1):109-11. doi: 10.1111/j.1440-1746.1998.tb00554.x.PMID: 9737581

NAFLD & METABOLIC DISEASES

SlNo	Title	Citations
	I. NAFLD AND METABOLIC DISEASES
1.	Duseja A, Dhiman RK, Premkumar M. Nonalcoholic Fatty Liver Disease: Lessons Learnt in the Last Five Years. J Clin Exp Hepatol. 2021 Mar-Apr;11(2):159-162. doi: 10.1016/j.jceh.2020.07.008. Epub 2020 Jul 24.PMID: 33746439 Free PMC article. No abstract available.
2.	Mahajan R, Dogra S, Handa S, Razmi TM, Narang T, Rathi S, Dhiman RK, Saikia B, Karim A. Metabolic syndrome and female gender, but not methotrexate, are the important associations of significant liver fibrosis in patients with moderate-to-severe psoriasis as detected by transient elastography. Indian J Dermatol VenereolLeprol. 2020 Nov-Dec;86(6):649-655. doi: 10.4103/ijdvl.IJDVL_152_19.PMID: 32643632 Free article.
3.	Nagral A, Sarma MS, Matthai J, Kukkle PL, Devarbhavi H, Sinha S, Alam S, Bavdekar A, Dhiman RK, Eapen CE, Goyal V, Mohan N, Kandadai RM, Sathiyasekaran M, Poddar U, Sibal A, Sankaranarayanan S, Srivastava A, Thapa BR, Wadia PM, Yachha SK, Dhawan A. Corrigendum to "Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for the Study of Liver (INASL), The Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN) and the Movement Disorders Society of India (MDSI)" [J Clin Exp Hepatol 9 (2019) 74-98]. J Clin Exp Hepatol. 2020 Jan-Feb;10(1):99. doi: 10.1016/j.jceh.2019.12.001. Epub 2019 Dec 10.PMID: 32025169 Free PMC article.
4.	Duseja A, Acharya SK, Mehta M, Chhabra S; Shalimar; Rana S, Das A, Dattagupta S, Dhiman RK, Chawla YK. High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study. BMJ Open Gastroenterol. 2019 Aug 7;6(1):e000315. doi: 10.1136/bmjgast-2019-000315. eCollection 2019.PMID: 31423319 Free PMC article.
5.	Nagral A, Sarma MS, Matthai J, Kukkle PL, Devarbhavi H, Sinha S, Alam S, Bavdekar A, Dhiman RK, Eapen CE, Goyal V, Mohan N, Kandadai RM, Sathiyasekaran M, Poddar U, Sibal A, Sankaranarayanan S, Srivastava A, Thapa BR, Wadia PM, Yachha SK, Dhawan A. Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India. J Clin Exp Hepatol. 2019 Jan-Feb;9(1):74-98. doi: 10.1016/j.jceh.2018.08.009. Epub 2018 Sep 3.PMID: 30765941 Free PMC article. Review.
6.	Nampoothiri RV, Duseja A, Rathi M, Agrawal S, Sachdeva N, Mehta M, Dhaliwal HS, Dhiman RK, Chawla Y. Renal Dysfunction in Patients with Nonalcoholic Fatty Liver Disease is Related to the Presence of Diabetes Mellitus and Severity of Liver Disease. J Clin Exp Hepatol. 2019 Jan-Feb;9(1):22-28. doi: 10.1016/j.jceh.2017.12.005. Epub 2017 Dec 30.PMID: 30765935 Free PMC article.
7.	Sakpal M, Satsangi S, Mehta M, Duseja A, Bhadada S, Das A, Dhiman RK, Chawla YK. Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial. JGH Open. 2017 Oct 12;1(2):62-67. doi: 10.1002/jgh3.12010. eCollection 2017 Oct.PMID: 30483536 Free PMC article.
8.	Mehta M, Satsangi S, Duseja A, Taneja S, Dhiman RK, Chawla Y. Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? J Clin Exp Hepatol. 2017 Jun;7(2):121-126. doi: 10.1016/j.jceh.2017.01.112. Epub 2017 Feb 3.PMID: 28663676 Free PMC article.
9.	Kapil S, Duseja A, Sharma BK, Singla B, Chakraborti A, Das A, Ray P, Dhiman RK, Chawla Y. Genetic polymorphism in CD14 gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease. World J Gastroenterol. 2016 Nov 14;22(42):9346-9355. doi: 10.3748/wjg.v22.i42.9346.PMID: 27895422 Free PMC article.
10.	Kapil S, Duseja A, Sharma BK, Singla B, Chakraborti A, Das A, Ray P, Dhiman RK, Chawla Y. Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2016 Jan;31(1):213-21. doi: 10.1111/jgh.13058.PMID: 26212089
11.	Duseja A, Singh SP, Saraswat VA, Acharya SK, Chawla YK, Chowdhury S, Dhiman RK, Jayakumar RV, Madan K, Misra SP, Mishra H, Modi SK, Muruganathan A, Saboo B, Sahay R, Upadhyay R. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J Clin Exp Hepatol. 2015 Mar;5(1):51-68. doi: 10.1016/j.jceh.2015.02.006. Epub 2015 Mar 6.PMID: 25941433 Free PMC article. Review.
12.	Agrawal S, Duseja A, Aggarwal A, Das A, Mehta M, Dhiman RK, Chawla Y. Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center. Hepatol Int. 2015 Apr;9(2):283-91. doi: 10.1007/s12072-015-9615-3. Epub 2015 Mar 12.PMID: 25788200
13.	Rana D, Duseja A, Dhiman RK, Chawla Y, Arora SK. Maturation defective myeloid dendritic cells in nonalcoholic fatty liver disease patients release inflammatory cytokines in response to endotoxin. Hepatol Int. 2013 Jun;7(2):562-9. doi: 10.1007/s12072-012-9371-6. Epub 2012 May 6.PMID: 26201788
14.	Kumar A, Sharma A, Duseja A, Das A, Dhiman RK, Chawla YK, Kohli KK, Bhansali A. Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis. J Clin Exp Hepatol. 2013 Mar;3(1):12-8. doi: 10.1016/j.jceh.2012.10.009. Epub 2012 Nov 2.PMID: 25755466 Free PMC article.
15.	Dhiman RK. Non-alcoholic Fatty Liver Disease Progression: All Depends on the Inflammasome Deficiency Driven Dysbiosis. J Clin Exp Hepatol. 2012 Jun;2(2):101-2. doi: 10.1016/S0973-6883(12)60095-4.PMID: 25755416 Free PMC article. No abstract available.
16.	Duseja A, Sharma B, Kumar A, Kapil S, Das A, Dhiman RK, Chawla YK. Nonalcoholic fatty liver in a developing country is responsible for significant liver disease. Hepatology. 2010 Dec;52(6):2248-9. doi: 10.1002/hep.23838. Epub 2010 Jul 29.PMID: 20725907 No abstract available.
17.	Kalra N, Duseja A, Das A, Dhiman RK, Virmani V, Chawla Y, Singh P, Khandelwal N. Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol. 2009 Jan-Mar;8(1):21-5.PMID: 19221529 Free article.
18.	Duseja A, Dhiman RK, Chawla YK. Chronic hepatitis C and diabetes mellitus--are they related? Trop Gastroenterol. 2008 Jul-Sep;29(3):121-2.PMID: 19115602 No abstract available.
19.	Duseja A, Das A, Dhiman RK, Chawla YK, Thumburu KT, Bhadada S, Bhansali A. Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. Ann Hepatol. 2007 Oct-Dec;6(4):222-6.PMID: 18007551 Free article. Clinical Trial.
20.	Duseja A, Thumburu KK, Das A, Dhiman RK, Chawla YK, Bhadada S, Bhansali A. Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease. Indian J Gastroenterol. 2007 Jul-Aug;26(4):170-3.PMID: 17986744
21.	Duseja A, Das A, Das R, Dhiman RK, Chawla Y, Bhansali A, Kalra N. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. Dig Dis Sci. 2007 Sep;52(9):2368-74. doi: 10.1007/s10620-006-9136-y. Epub 2007 Apr 10.PMID: 17420951
22.	Duseja A, Das A, Dhiman RK, Chawla YK, Das R, Bhadada S, Sialy R, Thumburu KK, Bhansali A, Kalra N. Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are different at presentation. World J Gastroenterol. 2007 Jan 28;13(4):649-50. doi: 10.3748/wjg.v13.i4.649.PMID: 17278239 Free PMC article. No abstract available.
23.	Duseja A, Das R, Das A, Dhiman RK, Chawla YK, Garewal G. Serum iron levels and hepatic iron overload in patients with nonalcoholic steatohepatitis. Dig Dis Sci. 2006 Oct;51(10):1730-1. doi: 10.1007/s10620-005-9041-9.PMID: 16964548 No abstract available.
24.	Duseja A, Das A, Das R, Dhiman RK, Chawla Y, Bhansali A. Unconjugated hyperbilirubinemia in nonalcoholic steatohepatitis--is it Gilbert's syndrome? Trop Gastroenterol. 2005 Jul-Sep;26(3):123-5.PMID: 16512459
25.	Dhiman RK, Duseja A, Chawla Y. Asians need different criteria for defining overweight and obesity. Arch Intern Med. 2005 May 9;165(9):1069-70. doi: 10.1001/archinte.165.9.1069-b.PMID: 15883250 No abstract available.
26.	Dhiman RK, Arke L, Bhansali A, Gupta S, Chawla YK. Cisapride improves gallbladder emptying in patients with type 2 diabetes mellitus. J Gastroenterol Hepatol. 2001 Sep;16(9):1044-50. doi: 10.1046/j.1440-1746.2001.02586.x.PMID: 11595071

MISCELLANEOUS

SlNo	Title
	I. MISCELLANEOUS
1.	Keshri A, Mathialagan A, Aishwarya A, Ravisankar, Bhuskute G, Kanaujia V, Singh AK, Singh RK, Dhiman RK, Agarwal R. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable. Eur Arch Otorhinolaryngol. 2023 Feb;280(2):819-827. doi: 10.1007/s00405-022-07620-3. Epub 2022 Sep 2.PMID: 36053359 Free PMC article.
2.	Hashim Z, Nath A, Khan A, Gupta M, Kumar A, Chatterjee R, Dhiman RK, Hoenigl M, Tripathy NK.Effect of glucocorticoids on the development of COVID-19-associated pulmonary aspergillosis: A meta-analysis of 21 studies and 5174 patients. Mycoses. 2023 Nov;66(11):941-952. doi: 10.1111/myc.13637. Epub 2023 Aug 7.PMID: 37551043
3.	Mishra K, Jandial A, Sandal R, Meshram A, Lad D, Prakash G, Khadwal A, Kapoor R, Ahluwalia J, Varma N, Varma S, Dhiman RK, Malhotra P.Bleeding risk assessment in immune thrombocytopenia.Ann Hematol. 2023 Nov;102(11):3007-3014. doi: 10.1007/s00277-023-05466-1. Epub 2023 Sep 23.PMID: 37740064
4.	Hashim Z, Nath A, Khan A, Neyaz Z, Marak RSK, Areekkara P, Tiwari A, Srivastava S, Agarwal V, Saxena S, Tripathy N, Azim A, Gupta M, Mishra DP, Mishra P, Singh RK, Gupta D, Gupta A, Sanjeev OP, Ghatak T, Ghoshal U, Dhiman RK, Tripathy NK. New insights into development and mortality of COVID-19-associated pulmonary aspergillosis in a homogenous cohort of 1161 intensive care patients.Mycoses. 2022 Nov;65(11):1010-1023. doi: 10.1111/myc.13485. Epub 2022 Jul 7.PMID: 35716344 Free PMC article.
5.	Baghel SS, Keshri AK, Mishra P, Marak R, Manogaran RS, Verma PK, Srivastava AK, Kumar R, Mathialagan A, Bhuskute G, Dubey AK, Dhiman RK. The Spectrum of Invasive Fungal Sinusitis in COVID-19 Patients: Experience from a Tertiary Care Referral Center in Northern India. J Fungi (Basel). 2022 Feb 24;8(3):223. doi: 10.3390/jof8030223.PMID: 35330225 Free PMC article.
6.	Gupta H, Nigam N, Singh S, Roy A, Dhiman RK. Immune Boosting Gone Wrong? A COVID-Concoction-Conundrum.J Clin Exp Hepatol. 2022 Jan-Feb;12(1):235-236. doi: 10.1016/j.jceh.2021.09.022. Epub 2021 Oct 2.PMID: 34629790 Free PMC article. No abstract available.
7.	Mishra P, Singh RK, Nath A, Pande S, Agarwal A, Sanjeev OP, Gupta D, Singh P, Ghatak T, Hashim Z, Khare V, Khuba S, Rastogi A, Dhiman RK. A novel epidemiological scoring system for the prediction of mortality in COVID-19 patients. Trans R Soc Trop Med Hyg. 2022 May 2;116(5):409-416. doi: 10.1093/trstmh/trab108.PMID: 34388241 Free PMC article.
8.	Ghoshal UC, Ghoshal U, Mathur A, Singh RK, Nath A, Garg A, Singh D, Singh S, Singh J, Pandey A, Rai S, Vasanth S, Dhiman RK. The Spectrum of Gastrointestinal Symptoms in Patients With Coronavirus Disease-19: Predictors, Relationship With Disease Severity, and Outcome. Clin Transl Gastroenterol. 2020 Dec;11(12):e00259. doi: 10.14309/ctg.0000000000000259.PMID: 33463978 Free PMC article.
9.	Roy A, Premkumar M, Mishra S, Mehtani R, Suri V, Aggarwal N, Singh S, Dhiman RK. Role of ursodeoxycholic acid on maternal serum bile acids and perinatal outcomes in intrahepatic cholestasis of pregnancy.Eur J Gastroenterol Hepatol. 2021 Apr 1;33(4):571-576. doi: 10.1097/MEG.0000000000001954.PMID: 33136720
10.	Ghoshal UC, Ghoshal U, Dhiman RK. Gastrointestinal and Hepatic Involvement in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Review. J Clin Exp Hepatol. 2020 Nov-Dec;10(6):622-628. doi: 10.1016/j.jceh.2020.06.002. Epub 2020 Jun 11.PMID: 32837095 Free PMC article. Review.
11.	Saigal S, Gupta S, Sudhindran S, Goyal N, Rastogi A, Jacob M, Raja K, Ramamurthy A, Asthana S, Dhiman RK, Singh B, Perumalla R, Malik A, Shanmugham N, Soin AS. Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI). Hepatol Int. 2020 Jul;14(4):429-431. doi: 10.1007/s12072-020-10041-1. Epub 2020 Apr 8.PMID: 32270388 Free PMC article.
12.	Gupta N, Verma R, Dhiman RK, Rajsekhar K, Prinja S. Cost-Effectiveness Analysis and Decision Modelling: A Tutorial for Clinicians. J Clin Exp Hepatol. 2020 Mar-Apr;10(2):177-184. doi: 10.1016/j.jceh.2019.11.001. Epub 2019 Nov 26.PMID: 32189934 Free PMC article. Review.
13.	Aj L, Kalra N, Bhatia A, Srinivasan R, Gulati A, Kapoor R, Gupta V, Dhiman RK, Chawla Y, Khandelwal N. Fusion Image-Guided and Ultrasound-Guided Fine Needle Aspiration in Patients with Suspected Hepatic Metastases. J Clin Exp Hepatol. 2019 Sep-Oct;9(5):547-553. doi: 10.1016/j.jceh.2019.01.003. Epub 2019 Jan 25.PMID: 31695243 Free PMC article.
14.	Arora A, Kumar A, Anand AC, Puri P, Dhiman RK, Acharya SK, Aggarwal K, Aggarwal N, Aggarwal R, Chawla YK, Dixit VK, Duseja A, Eapen CE, Goswami B, Gujral K, Gupta A, Jindal A, Kar P, Kumari K, Madan K, Malhotra J, Malhotra N, Pandey G, Pandey U, Puri RD, Rai RR, Rao PN, Sarin SK, Sharma A, Sharma P, Shenoy KT, Singh KR, Singh SP, Suri V, Trehanpati N, Wadhawan M. Indian National Association for the Study of the Liver-Federation of Obstetric and Gynaecological Societies of India Position Statement on Management of Liver Diseases in Pregnancy.J Clin Exp Hepatol. 2019 May-Jun;9(3):383-406. doi: 10.1016/j.jceh.2019.02.007. Epub 2019 Mar 6.PMID: 31360030 Free PMC article. Review.
15.	Kalra N, Gupta P, Singhal M, Gupta R, Gupta V, Srinivasan R, Mittal BR, Dhiman RK, Khandelwal N. Cross-sectional Imaging of Gallbladder Carcinoma: An Update. J Clin Exp Hepatol. 2019 May-Jun;9(3):334-344. doi: 10.1016/j.jceh.2018.04.005. Epub 2018 Apr 30.PMID: 31360026 Free PMC article. Review.
16.	Vadi SK, Mittal BR, Singh H, Kumar R, Dhiman RK. Incidental Detection of Urinary Bladder Herniation in ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Mimicking as Metastatic Deposit in the Inguinal Canal. Indian J Nucl Med. 2019 Jul-Sep;34(3):247-248. doi: 10.4103/ijnm.IJNM_38_19.PMID: 31293312 Free PMC article.
17.	Dhiman RK. The Ninth Year of JCEH: The Year of Expansion and Growth. J Clin Exp Hepatol. 2019 Jan-Feb;9(1):1. doi: 10.1016/j.jceh.2019.01.001. Epub 2019 Jan 25.PMID: 30765931 Free PMC article. No abstract available.
18.	Mitra S, Rathi S, Debi U, Dhiman RK, Das A. Primary Hepatic Leiomyosarcoma: Histopathologist's Perspective of a Rare Case. J Clin Exp Hepatol. 2018 Sep;8(3):321-326. doi: 10.1016/j.jceh.2018.04.015. Epub 2018 May 17.PMID: 30302051 Free PMC article.
19.	Taneja S, Kumar P, Mitra S, Duseja A, Minz R, Das A, Dhiman RK, Chawla Y. Acute Exacerbation to Autoimmune Hepatitis Mimicking Acute Viral Hepatitis-A Case Series and Review of Literature.J Clin Exp Hepatol. 2018 Mar;8(1):98-103. doi: 10.1016/j.jceh.2017.08.005. Epub 2017 Sep 1.PMID: 29743801 Free PMC article.
20.	Prabhakar N, Kalra N, Behera A, Das A, Lal A, Dhiman RK, Khandelwal N. Large Heterogeneous Calcified Masses in Liver: A Diagnostic Dilemma. J Clin Exp Hepatol. 2017 Dec;7(4):385-386. doi: 10.1016/j.jceh.2017.09.001. Epub 2017 Oct 3.PMID: 29234206 Free PMC article. No abstract available.
21.	Kumar P, Taneja S, Gupta K, Duseja A, Dhiman RK, Chawla YK. Unusual Presentation of Tubercular Liver Abscess in an Immune-Competent Adult. J Clin Exp Hepatol. 2017 Mar;7(1):77-79. doi: 10.1016/j.jceh.2016.09.011. Epub 2016 Sep 17.PMID: 28348476 Free PMC article.
22.	Taneja S, Kumar P, Duseja A, Singh V, Dhiman RK, Chawla Y. Honeycomb Cyst of the Liver. J Clin Exp Hepatol. 2016 Sep;6(3):250-251. doi: 10.1016/j.jceh.2016.03.001. Epub 2016 Mar 11.PMID: 27746624 Free PMC article. No abstract available.
23.	Agrawal S, Dhiman RK, Limdi JK. Evaluation of abnormal liver function tests. Postgrad Med J. 2016 Apr;92(1086):223-34. doi: 10.1136/postgradmedj-2015-133715. Epub 2016 Feb 3.PMID: 26842972 Review.
24.	Verma N, Bhalla A, Kumar S, Dhiman RK, Chawla YK.Wild mushroom poisoning in north India: case series with review of literature. J Clin Exp Hepatol. 2014 Dec;4(4):361-5. doi: 10.1016/j.jceh.2014.09.004. Epub 2014 Sep 26.PMID: 25755582 Free PMC article.
25.	Duseja A, Dhiman RK, Chawla Y, Kalra N, Behera A. Giant hydatid cyst of the liver. Trop Gastroenterol. 2013 Apr-Jun;34(2):112-3. doi: 10.7869/tg.2012.111.PMID: 24377163 No abstract available.
26.	Savlania A, Behera A, Vaiphei K, Singh H, Dhiman RK, Duseja A, Chawla YK. Primary leiomyosarcoma of gallbladder: a rare diagnosis. Case Rep Gastrointest Med. 2012;2012:287012. doi: 10.1155/2012/287012. Epub 2012 Aug 1.PMID: 22900213 Free PMC article.
27.	Kumar A, Ahuja CK, Vyas S, Kalra N, Khandelwal N, Chawla Y, Dhiman RK. Hepatic arteriovenous fistulae: role of interventional radiology. Dig Dis Sci. 2012 Oct;57(10):2703-12. doi: 10.1007/s10620-012-2331-0. Epub 2012 Aug 9.PMID: 22875308
28.	Guru Murthy GS, Rana BS, Das A, Thapa BR, Duseja AK, Dhiman RK, Chawla YK. Alagille syndrome: a rare disease in an adolescent. Dig Dis Sci. 2012 Nov;57(11):3035-7. doi: 10.1007/s10620-012-2226-0. Epub 2012 Jun 8.PMID: 22678460 No abstract available.
29.	Choudhary NS, Gupta S, Chawla YK, Duseja A, Dhiman RK, Das A. Azathioprine induced liver injury: a case report. Dig Dis Sci. 2012 Jun;57(6):1717-8. doi: 10.1007/s10620-012-2056-0. Epub 2012 Apr 22.PMID: 22526581 No abstract available.
30.	Dhiman RK. The Green Tea Polyphenol, Epigallocatechin-3-Gallate (EGCG)-One Step Forward in Antiviral Therapy Against Hepatitis C Virus. J Clin Exp Hepatol. 2011 Dec;1(3):159-60. doi: 10.1016/S0973-6883(11)60232-6.PMID: 25755380 Free PMC article. No abstract available.
31.	Menachery J, Chawla Y, Duseja A, Dhiman RK, Kalra N, Vankar S. Retroduodenal perforation without sphincterotomy: a case report. Dig Dis Sci. 2011 Feb;56(2):610-1. doi: 10.1007/s10620-010-1469-x. Epub 2010 Dec 8.PMID: 21140216 No abstract available.
32.	Aggarwal N, Chopra S, Suri V, Sikka P, Dhiman RK, Chawla Y. Pregnancy outcome in women with autoimmune hepatitis. Arch Gynecol Obstet. 2011 Jul;284(1):19-23. doi: 10.1007/s00404-010-1540-z. Epub 2010 Jun 25.PMID: 20577751
33.	Noor MT, Lal A, Kochhar R, Singhal M, Sidhu GS, Srinivasan R, Rawat A, Dutta U, Dhiman RK, Chawla YK, Singh K. Autoimmune pancreatitis: a report from India. JOP. 2010 May 5;11(3):213-9.PMID: 20442514 Free article.
34.	Gupta R, Chettri D, Sharma A, Duseja A, Dhiman RK, Chawla YK, Kalra N, Gupta A, Behera A. Pancreatic cysts causing biliary obstruction in von Hippel Lindau syndrome. JOP. 2008 May 8;9(3):313-6.PMID: 18469445
35.	Chhetri D, Gupta R, Duseja A, Dhiman RK, Chawla Y, Das A. Benign recurrent intrahepatic cholestasis (BRIC) in an adult. Trop Gastroenterol. 2007 Oct-Dec;28(4):186-7.PMID: 18416353
36.	Dhiman RK, Chawla YK. Hormone replacement therapy and gallstone disease: a real association. Digestion. 2008;77(1):1-3. doi: 10.1159/000113896. Epub 2008 Jan 21.PMID: 18212500 Free article. No abstract available.
37.	Dhiman RK, Chawla YK. Is there a link between oestrogen therapy and gallbladder disease? Expert Opin Drug Saf. 2006 Jan;5(1):117-29. doi: 10.1517/14740338.5.1.117.PMID: 16370961 Review.
38.	Duseja A, Nada R, Dhiman RK, Chawla YK, Kalra N, Prashad S, Karwasra RK. Eosinophilic cholangiopathy--a case report. Dig Dis Sci. 2005 Aug;50(8):1422-5. doi: 10.1007/s10620-005-2856-6.PMID: 16110830 Review. No abstract available.
39.	Duseja A, Jain P, Reddy CS, Sharma TR, Behera A, Dhiman RK, Chawla YK. Safety and efficacy of ERCP in pregnancy. GastrointestEndosc. 2005 Feb;61(2):352-3; author reply 353. doi: 10.1016/s0016-5107(04)02630-6.PMID: 15729268 No abstract available.
40.	Dhiman R, Yusif R, Nabar U, Albaqali A. Images of interest. Gastrointestinal: ischemic enteritis and sickle cell disease. J Gastroenterol Hepatol. 2004 Nov;19(11):1318. doi: 10.1111/j.1440-1746.2004.03630.x.PMID: 15482541 No abstract available.
41.	Dhiman RK, Sarkar PK, Sharma A, Vasishta K, Kohli KK, Gupta S, Suri S, Chawla Y. Alterations in gallbladder emptying and bile retention in the absence of changes in bile lithogenicity in postmenopausal women on hormone replacement therapy. Dig Dis Sci. 2004 Aug;49(7-8):1335-41. doi: 10.1023/b:ddas.0000037831.77490.06.PMID: 15387365
42.	Dhiman RK. Tuberculous peritonitis: towards a positive diagnosis. Dig Liver Dis. 2004 Mar;36(3):175-7. doi: 10.1016/j.dld.2003.12.006.PMID: 15046185 No abstract available.
43.	Wanchu A, Chawla Y, Dhiman RK, Sud A, Bambery P. Paucity of anti-hepatitis C virus antibodies in the serum of Indian patients with Sjogren's syndrome and inflammatory myositis. Indian J PatholMicrobiol. 2003 Apr;46(2):191-3.PMID: 15022906
44.	Dhiman RK. Herbal hepatoprotective agents: marketing gimmick or potential therapies? Trop Gastroenterol. 2003 Jul-Sep;24(3):160-2.PMID: 14978996 Review. No abstract available.
45.	Rajagopalan S, al-Arrayed S, Dhiman RK. Brunner's gland polyp with upper gastrointestinal bleeding managed by endoscopic polypectomy: a report of two cases. Trop Gastroenterol. 2003 Jul-Sep;24(3):133-4.PMID: 14978987
46.	Albaqali A, Ghuloom A, Al Arrayed A, Al Ajami A, Shome DK, Jamsheer A, Al Mahroos H, Jelacic S, Tarr PI, Kaplan BS, Dhiman RK. Hemolytic uremic syndrome in association with typhoid fever. Am J Kidney Dis. 2003 Mar;41(3):709-13. doi: 10.1053/ajkd.2003.50135.PMID: 12612998
47.	Dhiman RK, Saraswat VA, Naik SR. Ambulatory esophageal pH monitoring: technique, interpretations, and clinical indications. Dig Dis Sci. 2002 Feb;47(2):241-50. doi: 10.1023/a:1013763616262.PMID: 11855537 Review.
48.	Lamba JK, Dhiman RK, Singh R, Kohli KK. Correlation between omeprazole hydroxylase and CYP2C19 genotype in North Indians.Eur J Clin Pharmacol. 2001 Nov;57(9):649-52. doi: 10.1007/s002280100334.PMID: 11791894
49.	Dhiman RK, Reddi R, Sharma A, Singh R, Kohli KK, Gupta S, Suri S, Chawla Y. Cisapride improves gallbladder emptying and bile lipid composition in patients with gallstones. J Gastroenterol Hepatol. 2001 Jul;16(7):816-20. doi: 10.1046/j.1440-1746.2001.02518.x.PMID: 11446892 Clinical Trial.
50.	Lamba JK, Dhiman RK, Kohli KK. CYP2C19 genetic mutations in North Indians. Clin PharmacolTher. 2000 Sep;68(3):328-35. doi: 10.1067/mcp.2000.109365.PMID: 11014415
51.	Gupta S, Seith A, Dhiman RK, Chawla YK, Sud K, Kohli HS, Sakhuja V, Suri S. CT of liver cysts in patients with autosomal dominant polycystic kidney disease. Acta Radiol. 1999 Jul;40(4):444-8. doi: 10.3109/02841859909177762.PMID: 10394876
52.	Dhiman RK, Gupta S, Makharia G, Chawla Y, Behra A, Suri S. T-tube access for endoscopic sphincterotomy: a variant of combined percutaneous and endoscopic approach. Indian J Gastroenterol. 1999 Jan-Mar;18(1):29-30.PMID: 10063744
53.	Ghoshal UC, Saraswat VA, Aggarwal R, Misra A, Dhiman RK, Naik SR. Oesophageal motility and gastro-oesophageal reflux: effect of variceal eradication by endoscopic sclerotherapy. J Gastroenterol Hepatol. 1998 Oct;13(10):1033-8. doi: 10.1111/j.1440-1746.1998.tb00566.x.PMID: 9835320
54.	Sharma BC, Singh K, Dhiman RK. Gall bladder motility after endoscopic sphincterotomy. Gut. 1998 Jul;43(1):146. doi: 10.1136/gut.43.1.146.PMID: 9771420 Free PMC article. No abstract available.
55.	Chawla Y, Makharia G, Gupta S, Sharma TR, Dhiman RK, Gupta S. Bilobed gallbladder with gallstones and choledocholithiasis. Trop Gastroenterol. 1998 Apr-Jun;19(2):64.PMID: 9752754 No abstract available.
56.	Sharma BC, Agarwal DK, Dhiman RK, Baijal SS, Choudhuri G, Saraswat VA. Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect of bile acid therapy. Gastroenterology. 1998 Jul;115(1):124-8. doi: 10.1016/s0016-5085(98)70373-7.PMID: 9649467
57.	Baijal SS, Dhiman RK, Gupta S, Sharma BC, Roy S, Agarwal DK, Choudhuri G, Saraswat VA, Naik SR. Percutaneous transhepatic biliary drainage in the management of obstructive jaundice. Trop Gastroenterol. 1997 Oct-Dec;18(4):167-71.PMID: 9612100
58.	Seth AK, Chawla Y, Dhiman RK, Gupta S, Suri S, Dilawari JB. Caroli's disease: a central dot means a lot. Trop Gastroenterol. 1997 Oct-Dec;18(4):165-6.PMID: 9612099
59.	Lamba JK, Dhiman RK, Kohli KK. Genetic polymorphism of the hepatic cytochrome P450 2C19 in north Indian subjects. Clin PharmacolTher. 1998 Apr;63(4):422-7. doi: 10.1016/S0009-9236(98)90037-6.PMID: 9585796
60.	Dhiman RK, Poddar U, Sharma BC, Arora P, Saraswat VA, Pandey R, Naik SR. Membranous glomerulonephritis in association with ulcerative colitis. Indian J Gastroenterol. 1998 Apr;17(2):62.PMID: 9563224
61.	Seth AK, Dhiman RK, Gupta S, Gulati M, Chawla YK, Suri S, Dilawari JB. Combined percutaneous-endoscopic approach for biliary endoprosthesis placement. Indian J Gastroenterol. 1997 Oct;16(4):149-50.PMID: 9357188
62.	Agarwal DK, Sharma BC, Dhiman RK, Baijal SS, Choudhuri G, Saraswat VA. Effect of endoscopic sphincterotomy on gallbladder motility. Dig Dis Sci. 1997 Jul;42(7):1495-500. doi: 10.1023/a:1018874928946.PMID: 9246053
63.	Dhiman RK, Phanish MK, Chawla YK, Dilawari JB. Gallbladder motility and lithogenicity of bile in patients with choledocholithiasis after endoscopic sphincterotomy. J Hepatol. 1997 Jun;26(6):1300-5. doi: 10.1016/s0168-8278(97)80465-5.PMID: 9210617
64.	Dhar A, Chawla Y, Dhiman RK, Gulati M, Suri S, Dilawari J. Bifid pancreas: a case report. Trop Gastroenterol. 1997 Apr-Jun;18(2):75-7.PMID: 9323923
65.	Mittal BR, Dhiman RK, Maini A, Sewatkar AB, Das BK. Gastric emptying in patients with non ulcer dyspepsia (dysmotility type). Trop Gastroenterol. 1997 Apr-Jun;18(2):67-9.PMID: 9323919
66.	Duseja A, Dhiman RK, Chawla Y, Singh V, Gupta S, Suri S. Cysto-bilio-bronchial communication in a hydatid cyst of liver. Trop Gastroenterol. 1997 Jan-Mar;18(1):30-1.PMID: 9197172 No abstract available.
67.	Dhiman RK, Saraswat VA, Mishra A, Naik SR. Inclusion of supine period in short-duration pH monitoring is essential in diagnosis of gastroesophageal reflux disease. Dig Dis Sci. 1996 Apr;41(4):764-72. doi: 10.1007/BF02213133.PMID: 8674398
68.	Tripathy U, Dhiman RK, Attari A, Katariya RN, Ganguly NK, Chawla YK, Dilawari JB. Preoperative bile salt administration versus bile refeeding in obstructive jaundice. Natl Med J India. 1996 Mar-Apr;9(2):66-9.PMID: 8857040 Clinical Trial.
69.	Dhar A, Chawla Y, Dhiman RK, Suri S, Behera A, Bhansali A, Sud R, Katariya R, Dilawari J. Biliary obstruction due to pancreatic insulinoma. Dig Dis Sci. 1995 Nov;40(11):2368-72. doi: 10.1007/BF02063239.PMID: 7587816
70.	Ghosh D, Dhiman RK, Kohli A, Naik SR. Hypokalemic periodic paralysis in association with tropical sprue: a case report. Acta Neurol Scand. 1994 Nov;90(5):371-3. doi: 10.1111/j.1600-0404.1994.tb02740.x.PMID: 7887139 No abstract available.
71.	Saraswat VA, Dhiman RK, Mishra A, Naik SR. Correlation of 24-hr esophageal pH patterns with clinical features and endoscopy in gastroesophageal reflux disease. Dig Dis Sci. 1994 Jan;39(1):199-205. doi: 10.1007/BF02090083.PMID: 8281858
72.	Saraswat VA, Gupta R, Dhiman RK, Gujral RB. Biliary ascariasis: endoscopic extraction of a living worm from the bile duct. Endoscopy. 1993 Oct;25(8):552-3. doi: 10.1055/s-2007-1010403.PMID: 8287826 No abstract available.
73.	Dhiman RK, Choudhuri G, Agarwal DK, Tandon P, Sahi RP. Benign non-traumatic inflammatory stricture of the common bile duct. Indian J Gastroenterol. 1992 Oct;11(4):174-5.PMID: 1398793
74.	Transient achalasia of esophagus in tetanus.Dhiman RK, Choudhuri G, Baronia AK, Gaur A, Singh PK, Kohli A, Naik SR.Indian J Gastroenterol. 1992 Jul;11(3):139-40.PMID: 1506052
75.	Dhiman RK, Saraswat VA, Radhakrishnan S, Parashar A, Agarwal DK, Naik SR. Multiple venous thromboses and membranous obstruction of inferior vena cava in association with hereditary protein C deficiency: a case report. J Gastroenterol Hepatol. 1992 Jul-Aug;7(4):434-8. doi: 10.1111/j.1440-1746.1992.tb01014.x.PMID: 1387555
76.	Dhiman RK, Agarwal DK, Aggarwal R, Saraswat VA. Thrombolytic therapy in thrombotic obstruction of inferior vena cava. Indian J Gastroenterol. 1992 Apr;11(2):98.PMID: 1428045 No abstract available.
77.	Agarwal DK, Choudhuri G, Dhiman RK, Kapoor VK. Giant colonic diverticulae presenting as painless abdominal lump. Indian J Gastroenterol. 1992 Apr;11(2):90.PMID: 1428041 No abstract available.
78.	Saraswat VA, Agarwal DK, Baijal SS, Roy S, Choudhuri G, Dhiman RK, Bhandari L, Naik SR. Percutaneous catheter drainage of amoebic liver abscess. Clin Radiol. 1992 Mar;45(3):187-9. doi: 10.1016/s0009-9260(05)80639-7.PMID: 1555372
79.	Baronia AK, Singh PK, Dhiman RK. Intractable pharyngeal spasm following tracheal extubation in a patient with undiagnosed tetanus. Anesthesiology. 1991 Dec;75(6):1111. doi: 10.1097/00000542-199112000-00022.PMID: 1741500 Free article. No abstract available.
80.	Choudhuri G, Saraswat VA, Agarwal DK, Dhiman RK, Ahalawat R. Extra corporeal shock wave lithotripsy of bile duct stones: absence of short term complications with the use of very high number of shock waves. Indian J Gastroenterol. 1991 Apr;10(2):46-8.PMID: 2040511
81.	Mehrotra S, Dhiman RK, Sircar AR. Hyper-eosinophilic syndrome with lepromatous leprosy. J Assoc Physicians India. 1988 Apr;36(4):287-8.PMID: 3182684 No abstract available.

Books

a. Books/Chapters

i. Books

1. Supplements:

2. Monographs

d. Naik SR, Dhiman RK.

ii. Chapters

(In chronological order)

I. Dhiman RK, Premkumar M. Chronic viral hepatitis. In: API Textbook of Medicine; 12^th Ed.; 2022.

II. Dhiman RK and Rathi S. Hepatic encephalopathy: classification, diagnosis, and treatment. CHAPTER 44: Wiley-Blackwell / Evidence-Based Gastroenterology and Hepatology, 4e 2019.

III. Dhiman RK, Premkumar M. Chronic viral hepatitis. In: API Textbook of Medicine; 11^th Ed.; 2019.

IV. Dhiman RK. Chronic viral hepatitis. In: API Textbook of Medicine; 10^th Ed. YP Munjal; 2015.

V. Dhiman RK. Investigations in hepatic disorders. In: API Textbook of Medicine; 9^th Ed. YP Munjal; 2011

VI. Dhiman RK, Chawla YK: Noncirrhotic portal fibrosis. In: Tropical Hepatogastroenterology. Elsevier, Reed Elsevier India Private Limited. B.N. Tandon (ed.) 2008; 388-403

VII. Dhiman RK. Investigations in hepatic disorders. In: API Textbook of Medicine; 8^th Ed. SC Shah; 2008

VIII. Dhiman RK. What are the indications of liver transplantation in acute liver failure? In: 100 clinical questions in Gastroenterology. Ajay Kumar, Manav Wadhavan (eds.) 2007; 26-28.

IX. Dhiman RK, Solanki K. Management of Hepatic Encephalopathy: Seen and Unseen. In: Medicine UpdateVol 17; Ed YP Munjal.2007; pp 259-271.

X. Dhiman RK,Chawla Y, Vasistha RK. Noncirrhotic portal hypertension (Idiopathic portal hypertension). In: Portal Hypertension: Pathogenesis & Management; Ed Ahmed Helmy, 2005; pp 339-364.

XI. Dhiman RK, Chawla Y. Portal biliopathy. In: Portal Hypertension: Pathogenesis & Management; Ed Ahmed Helmy, 2005; pp 167-178.

XII. Dhiman RK,Duseja A. Nonalcoholic Fatty Liver Disease. In: Medicine UpdateVol 15; Ed S B Gupta.2005; pp 469-475.

XIII. Dilawari JB, Dhiman RK. Ed. N Kumar, SK Acharaya. Imaging of pancreas in tropical pancreatitis. Roussal Scientific Institute, India.1994, Pp 49-64.

XIV. Saraswat VA, Dhiman RK. Current concepts in gastroesophageal reflux disease. In SGPI Gastroenterology Clinics 1999. Workshop Mannual, SGPGIMS, Lucknow pp. 7-18.

XV. Dhiman RK, Naik SR. Acute hepatic encephalopathy: Newer therapeutic approach.In: Medicine Update Vol 2; Ed S Mukherjee.1992; pp 163-70.

XVI. Dhiman RK, Saraswat VA. Overt and subclinical hepatic encephalopathy: An overview of diagnosis and management. In Mediicine Update 1991; Ed Govil M; 272-279.

XVII. Dhiman RK, Saraswat VA. Ambulatory esophageal pH monitoring: technique, interpretations and clinical implications. SGPGIMS, Lucknow. Pp 37-50.

RESEARCH

RESEARCH

Research Projects & Grants

SlNo	Title of the Research Project	Principal/Co-Investigator	Duration of the Project	Agency	Financial Support
1	Nonalcoholic fatty liver disease, insulin resistance and metabolic syndrome: Is there an etiologic association?	Principal Investigator	3 years	ICMR	8.5 lacs
2	Alterations in gene expressions coding for key Astrocytic and neuronal proteins in patients who have died from acute liver failure or chronic liver failure associated with hepatic encephalopathy.	Principal Investigator	3 years	ICMR	20 lacs
3	Supplementation with a probiotic preparation, VSL#3® as a support pharmaceutical therapy in cirrhotic patients for the treatment of minimal hepatic encephalopathy (MHE). A double-blind, randomized, placebo-controlled study.	Principal Investigator	2 years	CD Pharma India Private Limited, New Delhi	11 lacs
4	To study the protective effect of Nrf2-ARE pathway against oxidative stress and inflammation in frontal cortex and cerebellum regions of brain in acute and chronic hyperammonemic rats.	Principal Investigator	3 years	ICMR	21 lacs
5	Patterns of Resistance-Associated Substitution in patients with chronic HCV infection following treatment with NSSA inhibitors in the Public Health setting.	Principal Investigator	3 years	ICMR	80 lacs
6	Minimal Hepatic Encephalopathy among Cirrhotics: A Cross Sectional, Clinico-Epidemiological, Multicentre, Nationwide Study: THE PREDICT STUDY	Principal Investigator	2 years	Abbott India Ltd	Re 3 lacs
7	Role of cytokines and oxidative stress in patients with non-alcoholic steatohepatitis.	Co-Investigator	2 years	ICMR	6.5 lacs
8	Comparison of ablative therapies in hepatocellular carcinoma.	Co-Investigator	3 years	ICMR	35 lacs
9	Apolipoprotein V3 (APO C3) and Patatin like Phospholipase Domain Containing Protein 3 (PNPLA3) Gene polymorphism and expression in patients with Non-alcoholic fatty liver disease (NAFLD).	Co-investigator	(2014- 2017)	ICMR	19.75 lacs
10	GS-US-334-0110: “A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg Positive, Chronic Hepatitis B.”	Co-investigator	(2013- 2017)	Gilead Life sciences	Rs 39 lacs
11	GS-US-334-0108: “A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg Negative, Chronic Hepatitis B.”	Co-investigator	(2013- 2017)	Gilead Life sciences	Rs 39 lacs
12	GS-US-334-0116: “A Phase 3b, Multi-center, Randomized, open label, Study to Evaluate the Safety and Efficacy of Sofosbuvir plus Ribavirin in treatment-naïve adults with chronic Genotype 1 or 3 Hepatitis C Virus Infection.’’	Co-investigator	(2013- 2015)	Gilead Life sciences	Rs 2 lacs
13	A Prospective, multi-centre, double – blind, randomized trial of Saroglitazar 4mg vs Placebo in patients with Nonalcoholic steatohepatitis.	Co-investigator	(2016- 2018)	Cadila Healthcare Limited,	Rs 15 lac
14	A cross-sectional, clinico-epidemiological, multicenter study to determine the prevalence of nonalcoholic Fatty Liver disease and Thyroid dysfunction in patients with metabolic syndrome, visiting Endocrinology and Gastroenterology/Hepatology outpatient departments of tertiary health care centres in India.	Co-investigator	(2016- 2017)	Abbot India Limited	Rs 2.5 lac
15	OPTIMIS - Outcomes of HCC patients treated with TACE followed or not followed by sorafenib and the influence of timing to initiate Sorafenib - non- interventional, post-authorization safety study	Co-investigator	(2015 - 2017)	Bayer India	Rs 6 lacs
16	Diabetes – Liver Disease Embrace - “Comprehensive action for metabolic health and wellbeing-integration of a diabetes intervention with a liver health program”	Co-investigator	(2013- 2016)	Liver Foundation Kolkata	Rs 10 lacs
17	A Case – Control study to investigate risk factors for Liver Cancer	Co-investigator	(2014- 2016)	TMH, Mumbai	Rs 11 Lacs

I. Supervise MD Theses = 28

II. Supervise PhD Theses = 4

Director Profile